Autnet的个人主页 - 老虎社区

Autnet

Autnet

暂无个人介绍

IP属地：未知

8关注

1粉丝

0主题

0勋章

2021-12-07

Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️

Vaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today

2021-12-02

Heal the world…. Make it a better place😊

抱歉，原内容已删除

2021-12-14

Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄

Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%

2021-12-04

Heal the world…make it a better place☘️☘️☘️

昨夜今晨：血崩！美股市场巨震，中概股再遭重击

2021-11-23

Hmmm… both

Nvidia or AMD: Which Stock Is the Better Buy?

2021-12-08

Thanks for the advice. Will seriously consider if selling is imminent… or later?

Apple Stock: What Happens When The Cash Runs Out?

2021-12-01

Let’s pray that vaccines available still continue to work on all variants…

Is a Stock Market Correction Coming? Here’s a Big Red Flag

2021-11-24

Bought some for long terms gain… 😄

抱歉，原内容已删除

2021-11-09

$Lucid Group Inc(LCID)$Up up all the way 😄

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4098678914535810","uuid":"4098678914535810","gmtCreate":1635575848318,"gmtModify":1636431495881,"name":"Autnet","pinyin":"autnet","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":8,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.04","exceedPercentage":"80.82%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":604441479,"gmtCreate":1639441708814,"gmtModify":1639441708882,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄","listText":"Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄","text":"Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604441479","repostId":"1133455327","repostType":4,"repost":{"id":"1133455327","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406792,"share":"https://www.laohu8.com/m/news/1133455327?lang=&edition=full","pubTime":"2021-12-13 22:46","market":"us","language":"en","title":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133455327","media":"Tiger Newspress","summary":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping ove","content":"<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133455327","content_text":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.\nA new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.","news_type":1},"isVote":1,"tweetType":1,"viewCount":466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602030171,"gmtCreate":1638937159242,"gmtModify":1638937159242,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Thanks for the advice. Will seriously consider if selling is imminent… or later?","listText":"Thanks for the advice. Will seriously consider if selling is imminent… or later?","text":"Thanks for the advice. Will seriously consider if selling is imminent… or later?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602030171","repostId":"1105817084","repostType":4,"repost":{"id":"1105817084","kind":"news","pubTimestamp":1638933976,"share":"https://www.laohu8.com/m/news/1105817084?lang=&edition=full","pubTime":"2021-12-08 11:26","market":"us","language":"en","title":"Apple Stock: What Happens When The Cash Runs Out?","url":"https://stock-news.laohu8.com/highlight/detail?id=1105817084","media":"TheStreet","summary":"Apple is about to run out of cash. This statement may sound lucrac is to most Apple stock  investors, since the Cupertino company has been a cash-generating machine in the past many years. But even the management team knows this to be true.Today, the Apple Maven talks about what has been happening to the iPhone maker’s once giant pile of cash, and what the declining balances may mean for shareholders.To be fair, “running out of cash” in this context does not mean that Apple’s checking accounts a","content":"<p>Apple is about to run out of cash. This statement may sound lucrac&nbsp;is to most Apple stock&nbsp;(<b>AAPL</b>)&nbsp;investors, since the Cupertino company has been a cash-generating machine in the past many years. But even the management team&nbsp;knows&nbsp;this to be true.</p>\n<p>Today, the Apple Maven talks about what has been happening to the iPhone maker’s once giant pile of cash, and what the declining balances may mean for shareholders.</p>\n<p><b>Apple heading to net cash neutral</b></p>\n<p>To be fair, “running out of cash” in this context does not mean that Apple’s checking accounts at the bank will dry out. It simply means that the company’s debt balances will roughly offset its cash position — i.e. Apple will become net cash neutral.</p>\n<p>The chart below shows the evolution of Apple’s gross cash (blue bars) and net cash (orange bars) balances since 2011. Ten years ago was when then-CEO Steve Jobs stepped down and turned the control of the company over to then-COO Tim Cook.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/435c5199979bc64d49899feed29d15fb\" tg-width=\"1200\" tg-height=\"723\" width=\"100%\" height=\"auto\"><span>Figure 2:Apple's cash position, fiscal 2012-2021.data from Seeking Alpha</span></p>\n<p>Starting in 2012, Apple began issuing debt for the first time in its history. By 2017, the company boasted the largest gross and net-of-debt cash balances that it had ever seen in its books. But since then, both numbers have been dwindling. This year’s $72 billion in net cash is less than half the amount of about four years ago.</p>\n<p><b>What happens when cash runs out?</b></p>\n<p>The chart below shows that, prior to Tim Cook as CEO, Apple was very timid at deploying its cash reserves. While capex and dividend payments increased quickly (large M&amp;A has never been a thing for Apple), buybacks skyrocketed. Apple has spent more than three times as much in share repurchases since 2018 than it did in capex and dividends combined.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e0ecee1dedf8551b616732dc7180c574\" tg-width=\"1200\" tg-height=\"694\" width=\"100%\" height=\"auto\"><span>Figure 3:Apple's cash deployment by major category.data from Seeking Alpha</span></p>\n<p>As Apple’s cash balance continues to dip, it is reasonable to expect the pace of share retirement to decline as well. This is true not only because of a leaner balance sheet, but because AAPL stock trades at a much richer price today — thus, it costs Apple more to buy back each share of its own equity.</p>\n<p>Why is this relevant for investors? Over the past decade, Apple’s shares outstanding have declined by 10 billion units to 16.7 billion. Share count is the denominator in EPS (earnings per share) and EPS is the denominator in price-to-earnings. Therefore, buybacks alone have probably been responsible for a good chunk of Apple stock’s climb in the past several years.</p>\n<p>At the current stock price of $165 apiece, Apple can afford to retire around 435 million more shares with its current net cash balance, or barely 3% of the float. After that point, the Cupertino company might need to scale back on repurchases or borrow in order to keep buying its stock.</p>\n<p><b>Should investors worry?</b></p>\n<p>I think that Apple stock could suffer, at least from deteriorated investor sentiment, if or once it begins to slow down the pace of its share buyback efforts. However, I also believe that this is only one aspect of the investment thesis that people should consider.</p>\n<p>I remain optimistic about Apple stock from a business fundamentals perspective. The Cupertino company seems to have found the sweet spot in demand for its products and services, which I believe bodes very well for AAPL in the foreseeable future.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: What Happens When The Cash Runs Out?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: What Happens When The Cash Runs Out?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-08 11:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/apple-stock-what-happens-when-the-cash-runs-out><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple is about to run out of cash. This statement may sound lucrac is to most Apple stock (AAPL) investors, since the Cupertino company has been a cash-generating machine in the past many years. But ...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/apple-stock-what-happens-when-the-cash-runs-out\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/apple-stock-what-happens-when-the-cash-runs-out","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105817084","content_text":"Apple is about to run out of cash. This statement may sound lucrac is to most Apple stock (AAPL) investors, since the Cupertino company has been a cash-generating machine in the past many years. But even the management team knows this to be true.\nToday, the Apple Maven talks about what has been happening to the iPhone maker’s once giant pile of cash, and what the declining balances may mean for shareholders.\nApple heading to net cash neutral\nTo be fair, “running out of cash” in this context does not mean that Apple’s checking accounts at the bank will dry out. It simply means that the company’s debt balances will roughly offset its cash position — i.e. Apple will become net cash neutral.\nThe chart below shows the evolution of Apple’s gross cash (blue bars) and net cash (orange bars) balances since 2011. Ten years ago was when then-CEO Steve Jobs stepped down and turned the control of the company over to then-COO Tim Cook.\nFigure 2:Apple's cash position, fiscal 2012-2021.data from Seeking Alpha\nStarting in 2012, Apple began issuing debt for the first time in its history. By 2017, the company boasted the largest gross and net-of-debt cash balances that it had ever seen in its books. But since then, both numbers have been dwindling. This year’s $72 billion in net cash is less than half the amount of about four years ago.\nWhat happens when cash runs out?\nThe chart below shows that, prior to Tim Cook as CEO, Apple was very timid at deploying its cash reserves. While capex and dividend payments increased quickly (large M&A has never been a thing for Apple), buybacks skyrocketed. Apple has spent more than three times as much in share repurchases since 2018 than it did in capex and dividends combined.\nFigure 3:Apple's cash deployment by major category.data from Seeking Alpha\nAs Apple’s cash balance continues to dip, it is reasonable to expect the pace of share retirement to decline as well. This is true not only because of a leaner balance sheet, but because AAPL stock trades at a much richer price today — thus, it costs Apple more to buy back each share of its own equity.\nWhy is this relevant for investors? Over the past decade, Apple’s shares outstanding have declined by 10 billion units to 16.7 billion. Share count is the denominator in EPS (earnings per share) and EPS is the denominator in price-to-earnings. Therefore, buybacks alone have probably been responsible for a good chunk of Apple stock’s climb in the past several years.\nAt the current stock price of $165 apiece, Apple can afford to retire around 435 million more shares with its current net cash balance, or barely 3% of the float. After that point, the Cupertino company might need to scale back on repurchases or borrow in order to keep buying its stock.\nShould investors worry?\nI think that Apple stock could suffer, at least from deteriorated investor sentiment, if or once it begins to slow down the pace of its share buyback efforts. However, I also believe that this is only one aspect of the investment thesis that people should consider.\nI remain optimistic about Apple stock from a business fundamentals perspective. The Cupertino company seems to have found the sweet spot in demand for its products and services, which I believe bodes very well for AAPL in the foreseeable future.","news_type":1},"isVote":1,"tweetType":1,"viewCount":613,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606181174,"gmtCreate":1638842955281,"gmtModify":1638842955385,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️","listText":"Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️","text":"Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606181174","repostId":"1165217690","repostType":2,"repost":{"id":"1165217690","kind":"news","pubTimestamp":1638841605,"share":"https://www.laohu8.com/m/news/1165217690?lang=&edition=full","pubTime":"2021-12-07 09:46","market":"us","language":"en","title":"Vaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1165217690","media":"InvestorPlace","summary":"Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactl","content":"<p>Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactly why. After more than a week of ominous reports on the omicron virus and mounting speculation about its severity, yesterday brought some welcome news. Dr. Anthony Fauci, White House chief medical officer and a trusted expert on the virus, stated yesterday that some clear preliminary data was finally starting to emerge on the severity of the new variant and that so far, the results looked“encouraging.”</p>\n<p>What’s Happening With Vaccine Stocks</p>\n<p>Since news of the new variant first began dominating media airwaves, vaccine producers have been scrambling to be the first to address the new Covid-19 strain that threatened to undo the work that sent their stocks up earlier this year. Today has seen all the prominent names among vaccine stocks plunge across the board. While this isn’t strictly due to Dr. Fauci’s comments, it’s possible that the demand for new vaccine innovations and treatments may not be as great as we feared only a few days ago.</p>\n<p><b>BioNTech</b>&nbsp;(NASDAQ:<b><u>BNTX</u></b>) has suffered the worst declines of the day among vaccine stocks, with shares down almost 19% as of this writing. Next in line is&nbsp;<b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>), which has fallen more than 13%. Then,&nbsp;<b>Novavax’s</b>(NASDAQ:<b><u>NVAX</u></b>)declines come in just shy of 12%. Rounding out the pack is&nbsp;<b>Pfizer</b>(NYSE:<b><u>PFE</u></b>), which is in the red by just over 5% as trading winds to a close today.</p>\n<p>Why It Matters</p>\n<p>The clearest indication we should take from today’s events is that market mentality is shifting. This is evidenced by the performances we’ve seen not just from vaccine stocks but from other sectors that were differently affected by the spreading variant news. As&nbsp;<i>InvestorPlace’</i>s Shrey Dua reports,&nbsp;cruise ship stocks&nbsp;such as&nbsp;<b>Royal Caribbean</b>(NYSE:<b><u>RCL</u></b>) and&nbsp;<b>Carnival</b>(NYSE:<b><u>CCL</u></b>) are back in the green today after a troubling week of variant concerns. The same can be said for airline stocks, as names such as&nbsp;<b>Delta</b>&nbsp;(NYSE:<b><u>DAL</u></b>) and&nbsp;<b>Southwest</b>&nbsp;(NYSE:<b><u>LUV</u></b>) have gained some altitude today.</p>\n<p>Of course, it’s too soon to tell what the future will look like. The preliminary results upon which Dr. Fauci commented are exactly that — preliminary. Scientists and medical researchers still have plenty of research to do before they will be able outline a bigger picture. Dr. Fauci was careful to add that while there does not seem to be a “great degree of severity” to the spreading variant, it is still too early for any definitive conclusions to be reached. Omicron is still very much a variant of concern.</p>\n<p>What It Means</p>\n<p>Even if the variant does not end up posing as serious a threat to highly vaccinated countries as has been speculated, the need for vaccines isn’t going to go away. Fear of the variant has spiked&nbsp;demand&nbsp;for vaccinations in the U.S., and many countries are still struggling to get more of their populations partially or fully vaccinated. The industry landscape may not end up looking quite as bleak close to home as some of us have feared. However, that doesn’t mean that the demand for vaccines won’t be increasing throughout the months ahead.</p>\n<p>This news certainly doesn’t mean that a bearish play on vaccine stocks is advisable. Far from it, in fact. Novavax has an&nbsp;important catalyst&nbsp;rapidly approaching as the World Health Organization (WHO) considers granting it emergency use authorization. More than likely, vaccine stocks will be quick to rebound.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 09:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/vaccine-stocks-why-mrna-bntx-nvax-pfe-stocks-are-stumbling-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactly why. After more than a week of ominous reports on the omicron virus and mounting speculation about...</p>\n\n<a href=\"https://investorplace.com/2021/12/vaccine-stocks-why-mrna-bntx-nvax-pfe-stocks-are-stumbling-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://investorplace.com/2021/12/vaccine-stocks-why-mrna-bntx-nvax-pfe-stocks-are-stumbling-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165217690","content_text":"Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactly why. After more than a week of ominous reports on the omicron virus and mounting speculation about its severity, yesterday brought some welcome news. Dr. Anthony Fauci, White House chief medical officer and a trusted expert on the virus, stated yesterday that some clear preliminary data was finally starting to emerge on the severity of the new variant and that so far, the results looked“encouraging.”\nWhat’s Happening With Vaccine Stocks\nSince news of the new variant first began dominating media airwaves, vaccine producers have been scrambling to be the first to address the new Covid-19 strain that threatened to undo the work that sent their stocks up earlier this year. Today has seen all the prominent names among vaccine stocks plunge across the board. While this isn’t strictly due to Dr. Fauci’s comments, it’s possible that the demand for new vaccine innovations and treatments may not be as great as we feared only a few days ago.\nBioNTech (NASDAQ:BNTX) has suffered the worst declines of the day among vaccine stocks, with shares down almost 19% as of this writing. Next in line is Moderna(NASDAQ:MRNA), which has fallen more than 13%. Then, Novavax’s(NASDAQ:NVAX)declines come in just shy of 12%. Rounding out the pack is Pfizer(NYSE:PFE), which is in the red by just over 5% as trading winds to a close today.\nWhy It Matters\nThe clearest indication we should take from today’s events is that market mentality is shifting. This is evidenced by the performances we’ve seen not just from vaccine stocks but from other sectors that were differently affected by the spreading variant news. As InvestorPlace’s Shrey Dua reports, cruise ship stocks such as Royal Caribbean(NYSE:RCL) and Carnival(NYSE:CCL) are back in the green today after a troubling week of variant concerns. The same can be said for airline stocks, as names such as Delta (NYSE:DAL) and Southwest (NYSE:LUV) have gained some altitude today.\nOf course, it’s too soon to tell what the future will look like. The preliminary results upon which Dr. Fauci commented are exactly that — preliminary. Scientists and medical researchers still have plenty of research to do before they will be able outline a bigger picture. Dr. Fauci was careful to add that while there does not seem to be a “great degree of severity” to the spreading variant, it is still too early for any definitive conclusions to be reached. Omicron is still very much a variant of concern.\nWhat It Means\nEven if the variant does not end up posing as serious a threat to highly vaccinated countries as has been speculated, the need for vaccines isn’t going to go away. Fear of the variant has spiked demand for vaccinations in the U.S., and many countries are still struggling to get more of their populations partially or fully vaccinated. The industry landscape may not end up looking quite as bleak close to home as some of us have feared. However, that doesn’t mean that the demand for vaccines won’t be increasing throughout the months ahead.\nThis news certainly doesn’t mean that a bearish play on vaccine stocks is advisable. Far from it, in fact. Novavax has an important catalyst rapidly approaching as the World Health Organization (WHO) considers granting it emergency use authorization. More than likely, vaccine stocks will be quick to rebound.","news_type":1},"isVote":1,"tweetType":1,"viewCount":678,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608007502,"gmtCreate":1638578434765,"gmtModify":1638578434765,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Heal the world…make it a better place☘️☘️☘️","listText":"Heal the world…make it a better place☘️☘️☘️","text":"Heal the world…make it a better place☘️☘️☘️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608007502","repostId":"1177965649","repostType":2,"repost":{"id":"1177965649","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638575220,"share":"https://www.laohu8.com/m/news/1177965649?lang=&edition=full","pubTime":"2021-12-04 07:47","market":"fut","language":"zh","title":"昨夜今晨：血崩！美股市场巨震，中概股再遭重击","url":"https://stock-news.laohu8.com/highlight/detail?id=1177965649","media":"老虎资讯综合","summary":"摘要：非农数据引发市场巨震，纳指大跌近2%；热门中概股集体大跌，滴滴跌逾22%；美国总统拜登正式签署短期支出法案，政府运营将持续到明年2月；IMF总裁预期全球经济增速将被下调>>>\n\n收盘：非农数据远","content":"<blockquote>\n <b>摘要：</b>非农数据引发市场巨震，纳指大跌近2%；热门中概股集体大跌，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>跌逾22%；美国总统拜登正式签署短期支出法案，政府运营将持续到明年2月；IMF总裁预期全球经济增速将被下调&gt;&gt;&gt;\n</blockquote>\n<p><b>收盘：非农数据远逊预期 美股周五收跌</b></p>\n<p>美东时间周五，对奥密克戎变异毒株的担忧情绪仍然主导市场，加上11月非农数据远逊预期，三大指数集体收跌，科技股遭到普遍抛售，纳指盘中一度跌超2.5%。截至收盘，道琼斯指数跌0.17%，报34,580.08点；标普500指数跌0.84%，报4,538.43点；纳斯达克指数跌1.92%，报15,085.50点。</p>\n<p><b>热门中概股普遍下挫，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>跌逾22%</b></p>\n<p>热门中概股集体大跌，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>跌8.23%，<a href=\"https://laohu8.com/S/JD\">京东</a>跌7.71%，微博跌6.34%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>跌8.16%，<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>跌7.15%，<a href=\"https://laohu8.com/S/BIDU\">百度</a>跌7.77%，<a href=\"https://laohu8.com/S/EDU\">新东方</a>跌9.22%，<a href=\"https://laohu8.com/S/NTES\">网易</a>跌6.90%，<a href=\"https://laohu8.com/S/TME\">腾讯音乐</a>跌11.94%，<a href=\"https://laohu8.com/S/IQ\">爱奇艺</a>跌15.74%，滴滴跌22.18%。</p>\n<p><b>本周美国WTI原油下跌2.8% 连续第六周录得跌幅</b></p>\n<p>美国原油期货价格丧失了周五早盘的涨幅，最终逆转收跌。该期货连续第六周录得跌幅。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格下跌24美分，跌幅0.4%，收于每桶66.26美元，盘中最高曾达到69.22美元。根据FactSet的数据，按照最活跃合约计算，本周WTI原油期货价格下跌2.8%，为连续第六周录得跌幅。</p>\n<p><b>黄金期货价格周五收高1.2% 本周下跌0.1%</b></p>\n<p>黄金期货价格周五收高，保住了美国11月非农就业数据公布后所获大部分涨幅。但本周金价录得跌幅。纽约商品交易所交投最活跃的2月黄金期货价格上涨21.20美元，涨幅1.2%，收于每盎司1783.90美元。本周黄金期货价格下跌近0.1%。</p>\n<p><b>欧股主要指数下跌，德国DAX30指数收跌0.7%</b></p>\n<p>德国DAX30指数周五收跌0.71%，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>指数跌0.14%，法国CAC40指数跌0.44%，欧洲斯托克50指数跌0.70%，西班牙IBEX35指数跌0.76%，意大利富时MIB指数跌0.27%。</p>\n<p><b>国际宏观</b></p>\n<p><a href=\"https://laohu8.com/NW/2188264524\" target=\"_blank\"><b>美国11月非农报告耐人寻味 新增就业年内最低但失业率下降</b></a></p>\n<p>美国11月非农就业人数录得今年最小增幅，失业率超预期降至4.2%，虽然这些数据看起来喜忧参半，但仍可能推动美联储加快撤出疫情期间的货币刺激措施。美国劳工部周五公布的数据显示，11月非农就人数增长21万，此前两个月的数据都被向上调整。劳动力参与率微升至61.8%。</p>\n<p><a href=\"https://laohu8.com/NW/2188520783\" target=\"_blank\"><b>IMF总裁预期全球经济增速将被下调 受omicron变种影响</b></a></p>\n<p>国际货币基金组织（IMF）总裁格奥尔基耶娃预计，随着omicron变异毒株的病例数量增加，该组织将削减对全球经济反弹的预期。“我们可能会下调10月份时对全球经济增长的一些预测，”格奥尔基耶娃周五在路透主办的会议上表示。她说，新的变异毒株“可能很快就会削弱信心”。</p>\n<p><a href=\"https://laohu8.com/NW/2188520361\" target=\"_blank\"><b>美国总统拜登正式签署短期支出法案 政府运营将持续到明年2月</b></a></p>\n<p>美国总统拜登当地时间12月3日正式签署了短期支出法案，避免了政府的停摆危机。然而，短期支出法案只能维持政府运营持续到2月18日，国会议员们依然需要在明年年初制定另一项拨款法案。</p>\n<p><a href=\"https://laohu8.com/NW/2188527747\" target=\"_blank\"><b>IMF喊话美联储：重视通胀风险 尽快加速taper</b></a></p>\n<p>国际货币基金组织（IMF）警告称，鉴于美国通胀风险上升，并且奥密克戎变异毒株造成了新的不确定性，美联储官员应加快收紧货币政策的步伐。IMF首席经济学家Gita Gopinath和货币与资本市场部门主管Tobias Adrian撰文称，新冠疫情的复苏以及奥密克戎变异毒株的蔓延大大增加了全球经济的不确定性。</p>\n<p><b>公司新闻</b></p>\n<p><b><a href=\"https://laohu8.com/S/MRK\">默沙东</a>将向加拿大提供至多100万疗程新冠药物</b></p>\n<p><a href=\"https://laohu8.com/S/MRK\">默沙东</a>周五表示，将向加拿大提供至多100万疗程的新冠口服药物molnupiravir。据悉，加拿大政府已确保将在2022年采购50万疗程的molnupiravir，剩下50万疗程正等待加拿大卫生部的批准。</p>\n<p><b><a href=\"https://laohu8.com/S/GOOG\">谷歌</a>和梅塔公司将再度面临被俄罗斯一法院罚款</b></p>\n<p>据媒体报道，俄罗斯首都莫斯科塔甘斯基第422号地方法院将于12月24日举行听证会，审理由俄联邦电信、信息技术和大众传媒监督局提交的<a href=\"https://laohu8.com/S/GOOG\">谷歌</a>和梅塔公司（原脸书公司）行政犯罪的记录。上述公司没有按照规定删除被俄罗斯官方禁止传播的信息和内容，或将面临最高达其年收入总额十分之一的罚款。</p>\n<p><b>福特目标在两年内成为全球第二大电动车销售商</b></p>\n<p>当地时间周五，<a href=\"https://laohu8.com/S/F\">福特汽车</a>首席运营官Lisa Drake表示，福特预计将在两年内成为全球第二大电动汽车销售商，年产量接近60万辆，仅次于<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>。据分析师预估，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>有望在2021年销售89万辆汽车。</p>\n<p><b>传<a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>考虑将新疫苗部门上市</b></p>\n<p>据媒体援引消息人士称，<a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>可能将其新成立的疫苗部门上市，以提高投资者的回报。知情人士透露，关于新疫苗部门上市的设想，阿斯利康仍处在早期阶段，公司高层已与顾问讨论了一系列可能性。</p>\n<p><b>推特调整高管团队</b></p>\n<p>据媒体周五报道，推特公司在一份监管文件中表示，负责推特设计和研究的Dantley Davis和工程主管Michael Montano将离开公司。推特表示，这些举措旨在提高问责、速度和运营效率。本周早些时候，推特联合创始人Jack Dorsey宣布辞去CEO一职。</p>\n<p><a href=\"https://laohu8.com/NW/2188200520\" target=\"_blank\"><b>加拿大鹅遭炮轰 股价创2020年3月以来最大周跌幅</b></a></p>\n<p><a href=\"https://laohu8.com/S/GOOS\">加拿大鹅</a>股价本周一度下跌21%，创下2020年3月以来的最差单周表现。近日，加拿大鹅品牌“不得退换”的“霸王条款”引发舆论热议。数据显示，该公司财年第二季度约25%的收入来自亚洲。</p>\n<p><a href=\"https://laohu8.com/NW/2188224515\" target=\"_blank\"><b>BioNTech首席执行官：公司有能力迅速推出针对Omicron的疫苗</b></a></p>\n<p>BioNTech首席执行官Ugur Sahin接受采访时表示，在奥密克戎变异病毒出现后，公司有能力迅速调整其新冠病毒疫苗以针对新变异体。Sahin表示：“我原则上相信，在某个特定的时间点，我们将需要一种专门针对这类变异病毒的新疫苗，但问题是需求是否像去年那样非常迫切。”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昨夜今晨：血崩！美股市场巨震，中概股再遭重击</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昨夜今晨：血崩！美股市场巨震，中概股再遭重击\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-04 07:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n <b>摘要：</b>非农数据引发市场巨震，纳指大跌近2%；热门中概股集体大跌，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>跌逾22%；美国总统拜登正式签署短期支出法案，政府运营将持续到明年2月；IMF总裁预期全球经济增速将被下调&gt;&gt;&gt;\n</blockquote>\n<p><b>收盘：非农数据远逊预期 美股周五收跌</b></p>\n<p>美东时间周五，对奥密克戎变异毒株的担忧情绪仍然主导市场，加上11月非农数据远逊预期，三大指数集体收跌，科技股遭到普遍抛售，纳指盘中一度跌超2.5%。截至收盘，道琼斯指数跌0.17%，报34,580.08点；标普500指数跌0.84%，报4,538.43点；纳斯达克指数跌1.92%，报15,085.50点。</p>\n<p><b>热门中概股普遍下挫，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>跌逾22%</b></p>\n<p>热门中概股集体大跌，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>跌8.23%，<a href=\"https://laohu8.com/S/JD\">京东</a>跌7.71%，微博跌6.34%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>跌8.16%，<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>跌7.15%，<a href=\"https://laohu8.com/S/BIDU\">百度</a>跌7.77%，<a href=\"https://laohu8.com/S/EDU\">新东方</a>跌9.22%，<a href=\"https://laohu8.com/S/NTES\">网易</a>跌6.90%，<a href=\"https://laohu8.com/S/TME\">腾讯音乐</a>跌11.94%，<a href=\"https://laohu8.com/S/IQ\">爱奇艺</a>跌15.74%，滴滴跌22.18%。</p>\n<p><b>本周美国WTI原油下跌2.8% 连续第六周录得跌幅</b></p>\n<p>美国原油期货价格丧失了周五早盘的涨幅，最终逆转收跌。该期货连续第六周录得跌幅。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格下跌24美分，跌幅0.4%，收于每桶66.26美元，盘中最高曾达到69.22美元。根据FactSet的数据，按照最活跃合约计算，本周WTI原油期货价格下跌2.8%，为连续第六周录得跌幅。</p>\n<p><b>黄金期货价格周五收高1.2% 本周下跌0.1%</b></p>\n<p>黄金期货价格周五收高，保住了美国11月非农就业数据公布后所获大部分涨幅。但本周金价录得跌幅。纽约商品交易所交投最活跃的2月黄金期货价格上涨21.20美元，涨幅1.2%，收于每盎司1783.90美元。本周黄金期货价格下跌近0.1%。</p>\n<p><b>欧股主要指数下跌，德国DAX30指数收跌0.7%</b></p>\n<p>德国DAX30指数周五收跌0.71%，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>指数跌0.14%，法国CAC40指数跌0.44%，欧洲斯托克50指数跌0.70%，西班牙IBEX35指数跌0.76%，意大利富时MIB指数跌0.27%。</p>\n<p><b>国际宏观</b></p>\n<p><a href=\"https://laohu8.com/NW/2188264524\" target=\"_blank\"><b>美国11月非农报告耐人寻味 新增就业年内最低但失业率下降</b></a></p>\n<p>美国11月非农就业人数录得今年最小增幅，失业率超预期降至4.2%，虽然这些数据看起来喜忧参半，但仍可能推动美联储加快撤出疫情期间的货币刺激措施。美国劳工部周五公布的数据显示，11月非农就人数增长21万，此前两个月的数据都被向上调整。劳动力参与率微升至61.8%。</p>\n<p><a href=\"https://laohu8.com/NW/2188520783\" target=\"_blank\"><b>IMF总裁预期全球经济增速将被下调 受omicron变种影响</b></a></p>\n<p>国际货币基金组织（IMF）总裁格奥尔基耶娃预计，随着omicron变异毒株的病例数量增加，该组织将削减对全球经济反弹的预期。“我们可能会下调10月份时对全球经济增长的一些预测，”格奥尔基耶娃周五在路透主办的会议上表示。她说，新的变异毒株“可能很快就会削弱信心”。</p>\n<p><a href=\"https://laohu8.com/NW/2188520361\" target=\"_blank\"><b>美国总统拜登正式签署短期支出法案 政府运营将持续到明年2月</b></a></p>\n<p>美国总统拜登当地时间12月3日正式签署了短期支出法案，避免了政府的停摆危机。然而，短期支出法案只能维持政府运营持续到2月18日，国会议员们依然需要在明年年初制定另一项拨款法案。</p>\n<p><a href=\"https://laohu8.com/NW/2188527747\" target=\"_blank\"><b>IMF喊话美联储：重视通胀风险 尽快加速taper</b></a></p>\n<p>国际货币基金组织（IMF）警告称，鉴于美国通胀风险上升，并且奥密克戎变异毒株造成了新的不确定性，美联储官员应加快收紧货币政策的步伐。IMF首席经济学家Gita Gopinath和货币与资本市场部门主管Tobias Adrian撰文称，新冠疫情的复苏以及奥密克戎变异毒株的蔓延大大增加了全球经济的不确定性。</p>\n<p><b>公司新闻</b></p>\n<p><b><a href=\"https://laohu8.com/S/MRK\">默沙东</a>将向加拿大提供至多100万疗程新冠药物</b></p>\n<p><a href=\"https://laohu8.com/S/MRK\">默沙东</a>周五表示，将向加拿大提供至多100万疗程的新冠口服药物molnupiravir。据悉，加拿大政府已确保将在2022年采购50万疗程的molnupiravir，剩下50万疗程正等待加拿大卫生部的批准。</p>\n<p><b><a href=\"https://laohu8.com/S/GOOG\">谷歌</a>和梅塔公司将再度面临被俄罗斯一法院罚款</b></p>\n<p>据媒体报道，俄罗斯首都莫斯科塔甘斯基第422号地方法院将于12月24日举行听证会，审理由俄联邦电信、信息技术和大众传媒监督局提交的<a href=\"https://laohu8.com/S/GOOG\">谷歌</a>和梅塔公司（原脸书公司）行政犯罪的记录。上述公司没有按照规定删除被俄罗斯官方禁止传播的信息和内容，或将面临最高达其年收入总额十分之一的罚款。</p>\n<p><b>福特目标在两年内成为全球第二大电动车销售商</b></p>\n<p>当地时间周五，<a href=\"https://laohu8.com/S/F\">福特汽车</a>首席运营官Lisa Drake表示，福特预计将在两年内成为全球第二大电动汽车销售商，年产量接近60万辆，仅次于<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>。据分析师预估，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>有望在2021年销售89万辆汽车。</p>\n<p><b>传<a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>考虑将新疫苗部门上市</b></p>\n<p>据媒体援引消息人士称，<a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>可能将其新成立的疫苗部门上市，以提高投资者的回报。知情人士透露，关于新疫苗部门上市的设想，阿斯利康仍处在早期阶段，公司高层已与顾问讨论了一系列可能性。</p>\n<p><b>推特调整高管团队</b></p>\n<p>据媒体周五报道，推特公司在一份监管文件中表示，负责推特设计和研究的Dantley Davis和工程主管Michael Montano将离开公司。推特表示，这些举措旨在提高问责、速度和运营效率。本周早些时候，推特联合创始人Jack Dorsey宣布辞去CEO一职。</p>\n<p><a href=\"https://laohu8.com/NW/2188200520\" target=\"_blank\"><b>加拿大鹅遭炮轰 股价创2020年3月以来最大周跌幅</b></a></p>\n<p><a href=\"https://laohu8.com/S/GOOS\">加拿大鹅</a>股价本周一度下跌21%，创下2020年3月以来的最差单周表现。近日，加拿大鹅品牌“不得退换”的“霸王条款”引发舆论热议。数据显示，该公司财年第二季度约25%的收入来自亚洲。</p>\n<p><a href=\"https://laohu8.com/NW/2188224515\" target=\"_blank\"><b>BioNTech首席执行官：公司有能力迅速推出针对Omicron的疫苗</b></a></p>\n<p>BioNTech首席执行官Ugur Sahin接受采访时表示，在奥密克戎变异病毒出现后，公司有能力迅速调整其新冠病毒疫苗以针对新变异体。Sahin表示：“我原则上相信，在某个特定的时间点，我们将需要一种专门针对这类变异病毒的新疫苗，但问题是需求是否像去年那样非常迫切。”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/b23574aac95526c9e5c62ebc8dd25130","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数",".DJI":"道琼斯","TTTN":"老虎中美互联网巨头ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177965649","content_text":"摘要：非农数据引发市场巨震，纳指大跌近2%；热门中概股集体大跌，滴滴跌逾22%；美国总统拜登正式签署短期支出法案，政府运营将持续到明年2月；IMF总裁预期全球经济增速将被下调>>>\n\n收盘：非农数据远逊预期 美股周五收跌\n美东时间周五，对奥密克戎变异毒株的担忧情绪仍然主导市场，加上11月非农数据远逊预期，三大指数集体收跌，科技股遭到普遍抛售，纳指盘中一度跌超2.5%。截至收盘，道琼斯指数跌0.17%，报34,580.08点；标普500指数跌0.84%，报4,538.43点；纳斯达克指数跌1.92%，报15,085.50点。\n热门中概股普遍下挫，滴滴跌逾22%\n热门中概股集体大跌，阿里巴巴跌8.23%，京东跌7.71%，微博跌6.34%，拼多多跌8.16%，哔哩哔哩跌7.15%，百度跌7.77%，新东方跌9.22%，网易跌6.90%，腾讯音乐跌11.94%，爱奇艺跌15.74%，滴滴跌22.18%。\n本周美国WTI原油下跌2.8% 连续第六周录得跌幅\n美国原油期货价格丧失了周五早盘的涨幅，最终逆转收跌。该期货连续第六周录得跌幅。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格下跌24美分，跌幅0.4%，收于每桶66.26美元，盘中最高曾达到69.22美元。根据FactSet的数据，按照最活跃合约计算，本周WTI原油期货价格下跌2.8%，为连续第六周录得跌幅。\n黄金期货价格周五收高1.2% 本周下跌0.1%\n黄金期货价格周五收高，保住了美国11月非农就业数据公布后所获大部分涨幅。但本周金价录得跌幅。纽约商品交易所交投最活跃的2月黄金期货价格上涨21.20美元，涨幅1.2%，收于每盎司1783.90美元。本周黄金期货价格下跌近0.1%。\n欧股主要指数下跌，德国DAX30指数收跌0.7%\n德国DAX30指数周五收跌0.71%，英国富时100指数跌0.14%，法国CAC40指数跌0.44%，欧洲斯托克50指数跌0.70%，西班牙IBEX35指数跌0.76%，意大利富时MIB指数跌0.27%。\n国际宏观\n美国11月非农报告耐人寻味 新增就业年内最低但失业率下降\n美国11月非农就业人数录得今年最小增幅，失业率超预期降至4.2%，虽然这些数据看起来喜忧参半，但仍可能推动美联储加快撤出疫情期间的货币刺激措施。美国劳工部周五公布的数据显示，11月非农就人数增长21万，此前两个月的数据都被向上调整。劳动力参与率微升至61.8%。\nIMF总裁预期全球经济增速将被下调 受omicron变种影响\n国际货币基金组织（IMF）总裁格奥尔基耶娃预计，随着omicron变异毒株的病例数量增加，该组织将削减对全球经济反弹的预期。“我们可能会下调10月份时对全球经济增长的一些预测，”格奥尔基耶娃周五在路透主办的会议上表示。她说，新的变异毒株“可能很快就会削弱信心”。\n美国总统拜登正式签署短期支出法案 政府运营将持续到明年2月\n美国总统拜登当地时间12月3日正式签署了短期支出法案，避免了政府的停摆危机。然而，短期支出法案只能维持政府运营持续到2月18日，国会议员们依然需要在明年年初制定另一项拨款法案。\nIMF喊话美联储：重视通胀风险 尽快加速taper\n国际货币基金组织（IMF）警告称，鉴于美国通胀风险上升，并且奥密克戎变异毒株造成了新的不确定性，美联储官员应加快收紧货币政策的步伐。IMF首席经济学家Gita Gopinath和货币与资本市场部门主管Tobias Adrian撰文称，新冠疫情的复苏以及奥密克戎变异毒株的蔓延大大增加了全球经济的不确定性。\n公司新闻\n默沙东将向加拿大提供至多100万疗程新冠药物\n默沙东周五表示，将向加拿大提供至多100万疗程的新冠口服药物molnupiravir。据悉，加拿大政府已确保将在2022年采购50万疗程的molnupiravir，剩下50万疗程正等待加拿大卫生部的批准。\n谷歌和梅塔公司将再度面临被俄罗斯一法院罚款\n据媒体报道，俄罗斯首都莫斯科塔甘斯基第422号地方法院将于12月24日举行听证会，审理由俄联邦电信、信息技术和大众传媒监督局提交的谷歌和梅塔公司（原脸书公司）行政犯罪的记录。上述公司没有按照规定删除被俄罗斯官方禁止传播的信息和内容，或将面临最高达其年收入总额十分之一的罚款。\n福特目标在两年内成为全球第二大电动车销售商\n当地时间周五，福特汽车首席运营官Lisa Drake表示，福特预计将在两年内成为全球第二大电动汽车销售商，年产量接近60万辆，仅次于特斯拉。据分析师预估，特斯拉有望在2021年销售89万辆汽车。\n传阿斯利康考虑将新疫苗部门上市\n据媒体援引消息人士称，阿斯利康可能将其新成立的疫苗部门上市，以提高投资者的回报。知情人士透露，关于新疫苗部门上市的设想，阿斯利康仍处在早期阶段，公司高层已与顾问讨论了一系列可能性。\n推特调整高管团队\n据媒体周五报道，推特公司在一份监管文件中表示，负责推特设计和研究的Dantley Davis和工程主管Michael Montano将离开公司。推特表示，这些举措旨在提高问责、速度和运营效率。本周早些时候，推特联合创始人Jack Dorsey宣布辞去CEO一职。\n加拿大鹅遭炮轰 股价创2020年3月以来最大周跌幅\n加拿大鹅股价本周一度下跌21%，创下2020年3月以来的最差单周表现。近日，加拿大鹅品牌“不得退换”的“霸王条款”引发舆论热议。数据显示，该公司财年第二季度约25%的收入来自亚洲。\nBioNTech首席执行官：公司有能力迅速推出针对Omicron的疫苗\nBioNTech首席执行官Ugur Sahin接受采访时表示，在奥密克戎变异病毒出现后，公司有能力迅速调整其新冠病毒疫苗以针对新变异体。Sahin表示：“我原则上相信，在某个特定的时间点，我们将需要一种专门针对这类变异病毒的新疫苗，但问题是需求是否像去年那样非常迫切。”","news_type":1},"isVote":1,"tweetType":1,"viewCount":512,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603626872,"gmtCreate":1638407150732,"gmtModify":1638407150803,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Heal the world…. Make it a better place😊","listText":"Heal the world…. Make it a better place😊","text":"Heal the world…. Make it a better place😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/603626872","repostId":"1196358645","repostType":4,"repost":{"id":"1196358645","kind":"news","pubTimestamp":1638399984,"share":"https://www.laohu8.com/m/news/1196358645?lang=&edition=full","pubTime":"2021-12-02 07:06","market":"us","language":"en","title":"Wall St turns red as Omicron reaches the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=1196358645","media":"StreetInsider","summary":"Wall Street's major averages fell more than 1% on Wednesday after a morning rally faded as investor ","content":"<p>Wall Street's major averages fell more than 1% on Wednesday after a morning rally faded as investor angst about the latest coronavirus variant soared with the first U.S. case confirmation while the market also digested Fed comments on inflation.</p>\n<p>After having advanced as much as 1.9% by late morning, the S&amp;P 500 gave up all its gains in the afternoon along with the Dow and Nasdaq, which fell the most on the day. All three indexes breached key technical levels during the session.</p>\n<p>Late in the day, the U.S. Centers for Disease Control said the country had detected its first case of the Omicron variant, which had infected a person who came from South Africa, where the variant was initially discovered.</p>\n<p>Earlier on Wednesday, Federal Reserve ChairJerome Powellsaid policymakers needed to be ready to respond to the possibility inflation may not recede in the second half of next year as expected.</p>\n<p>Wall Street had already tumbled on Tuesday after Powell had surprised the market by signaling that the central bank would consider accelerating the withdrawal of its bond buying program at its December meeting amid a surge in inflation.</p>\n<p>\"The market's grappling with the twin concerns of the Omicron variant, which may or may not be able to evade the vaccine, and a more hawkish Powell than expected,\" said Chris Zaccarelli the chief investment officer at Independent Advisor Alliance in Charlotte, North Carolina.</p>\n<p>Wall Street had tumbled sharply on Friday when investors first heard of the Omicron variant with health officials saying they were unsure how transmissible or dangerous the variant is and how much protection existing vaccines provide.</p>\n<p>On Monday, the market rebounded sharply as investors looked for bargains after the sell-off, only to fall again on Tuesday following the Powell comments. [.N/C]</p>\n<p>\"We tried to buy the dip again (on Wednesday) but news that Omicron is here already has taken some of the wind out of the sails of the bulls,\" said Zaccarelli.</p>\n<p>The Dow Jones Industrial Average fell 461.68 points, or 1.34%, to 34,022.04, the S&amp;P 500 lost 53.96 points, or 1.18%, to 4,513.04 and the Nasdaq Composite dropped 283.64 points, or 1.83%, to 15,254.05.</p>\n<p>The Dow closed below its 200-day moving average for first time since July 13, 2020, while the S&amp;P finished below its 50-day moving average for first time since Oct. 13 and Nasdaq ended a session under its 50-day moving average for first time since Oct. 14.</p>\n<p>While all of the 11 major S&amp;P sectors were gaining into the early afternoon, all but one sector ended the day in the red. The communications services sector was the biggest loser with a 1.99% drop and consumer discretionary was not far behind with a 1.86% dip.</p>\n<p>The sole advancing sector was utilities, a more defensive sector which tends to draw interest when investors are fleeing from riskier bets. The next best performers on the day were also defensive sectors with the healthcare ending down 0.2% and consumer staples falling 0.4%.</p>\n<p>The CBOE market volatility index, often referred to as Wall Street's fear gauge, closed up 14.5 points at 31.12 after earlier rising to 32.61, its highest level since February.</p>\n<p>The economically sensitive Russell 2000 index of small cap companies did an almost complete about-face, closing down 2.3% after rising as much as 2.5% at its late morning peak.</p>\n<p>The World Health Organization said it expected to have more information on the transmissibility of the Omicron variant within days, and that the agency believes the existing COVID-19 vaccines will work against the variant.</p>\n<p>Lauren Goodwin, economist and portfolio strategist at New York Life Investments, said it was not surprising to see volatility as investors digest uncertainties including the lack of information on Omicron and the latest signals from the Fed.</p>\n<p>However Goodwin also pointed at Wednesday's positive economic data, which was \"reminding investors that the economic and corporate backdrop for this market is really strong.\"</p>\n<p>U.S. manufacturing activity picked up in November amid strong demand for goods.</p>\n<p>Salesforce.com Inc forecast current-quarter profit below estimates as it faces stiff competition from rivals including Microsoft, sending its shares down 11.7%.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.26-to-1 ratio; on Nasdaq, a 2.96-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 13 new 52-week highs and 42 new lows; the Nasdaq Composite recorded 37 new highs and 541 new lows.</p>\n<p>Trading volume was elevated with 14.2 billion shares changing hands on U.S. exchanges, compared with the 11.3 billion average for the last 20 sessions.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St turns red as Omicron reaches the United States</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St turns red as Omicron reaches the United States\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-02 07:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Market+Check/Wall+St+turns+red+as+Omicron+reaches+the+United+States/19292899.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wall Street's major averages fell more than 1% on Wednesday after a morning rally faded as investor angst about the latest coronavirus variant soared with the first U.S. case confirmation while the ...</p>\n\n<a href=\"https://www.streetinsider.com/Market+Check/Wall+St+turns+red+as+Omicron+reaches+the+United+States/19292899.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.streetinsider.com/Market+Check/Wall+St+turns+red+as+Omicron+reaches+the+United+States/19292899.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196358645","content_text":"Wall Street's major averages fell more than 1% on Wednesday after a morning rally faded as investor angst about the latest coronavirus variant soared with the first U.S. case confirmation while the market also digested Fed comments on inflation.\nAfter having advanced as much as 1.9% by late morning, the S&P 500 gave up all its gains in the afternoon along with the Dow and Nasdaq, which fell the most on the day. All three indexes breached key technical levels during the session.\nLate in the day, the U.S. Centers for Disease Control said the country had detected its first case of the Omicron variant, which had infected a person who came from South Africa, where the variant was initially discovered.\nEarlier on Wednesday, Federal Reserve ChairJerome Powellsaid policymakers needed to be ready to respond to the possibility inflation may not recede in the second half of next year as expected.\nWall Street had already tumbled on Tuesday after Powell had surprised the market by signaling that the central bank would consider accelerating the withdrawal of its bond buying program at its December meeting amid a surge in inflation.\n\"The market's grappling with the twin concerns of the Omicron variant, which may or may not be able to evade the vaccine, and a more hawkish Powell than expected,\" said Chris Zaccarelli the chief investment officer at Independent Advisor Alliance in Charlotte, North Carolina.\nWall Street had tumbled sharply on Friday when investors first heard of the Omicron variant with health officials saying they were unsure how transmissible or dangerous the variant is and how much protection existing vaccines provide.\nOn Monday, the market rebounded sharply as investors looked for bargains after the sell-off, only to fall again on Tuesday following the Powell comments. [.N/C]\n\"We tried to buy the dip again (on Wednesday) but news that Omicron is here already has taken some of the wind out of the sails of the bulls,\" said Zaccarelli.\nThe Dow Jones Industrial Average fell 461.68 points, or 1.34%, to 34,022.04, the S&P 500 lost 53.96 points, or 1.18%, to 4,513.04 and the Nasdaq Composite dropped 283.64 points, or 1.83%, to 15,254.05.\nThe Dow closed below its 200-day moving average for first time since July 13, 2020, while the S&P finished below its 50-day moving average for first time since Oct. 13 and Nasdaq ended a session under its 50-day moving average for first time since Oct. 14.\nWhile all of the 11 major S&P sectors were gaining into the early afternoon, all but one sector ended the day in the red. The communications services sector was the biggest loser with a 1.99% drop and consumer discretionary was not far behind with a 1.86% dip.\nThe sole advancing sector was utilities, a more defensive sector which tends to draw interest when investors are fleeing from riskier bets. The next best performers on the day were also defensive sectors with the healthcare ending down 0.2% and consumer staples falling 0.4%.\nThe CBOE market volatility index, often referred to as Wall Street's fear gauge, closed up 14.5 points at 31.12 after earlier rising to 32.61, its highest level since February.\nThe economically sensitive Russell 2000 index of small cap companies did an almost complete about-face, closing down 2.3% after rising as much as 2.5% at its late morning peak.\nThe World Health Organization said it expected to have more information on the transmissibility of the Omicron variant within days, and that the agency believes the existing COVID-19 vaccines will work against the variant.\nLauren Goodwin, economist and portfolio strategist at New York Life Investments, said it was not surprising to see volatility as investors digest uncertainties including the lack of information on Omicron and the latest signals from the Fed.\nHowever Goodwin also pointed at Wednesday's positive economic data, which was \"reminding investors that the economic and corporate backdrop for this market is really strong.\"\nU.S. manufacturing activity picked up in November amid strong demand for goods.\nSalesforce.com Inc forecast current-quarter profit below estimates as it faces stiff competition from rivals including Microsoft, sending its shares down 11.7%.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.26-to-1 ratio; on Nasdaq, a 2.96-to-1 ratio favored decliners.\nThe S&P 500 posted 13 new 52-week highs and 42 new lows; the Nasdaq Composite recorded 37 new highs and 541 new lows.\nTrading volume was elevated with 14.2 billion shares changing hands on U.S. exchanges, compared with the 11.3 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":773,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609779087,"gmtCreate":1638332392917,"gmtModify":1638332392917,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Let’s pray that vaccines available still continue to work on all variants…","listText":"Let’s pray that vaccines available still continue to work on all variants…","text":"Let’s pray that vaccines available still continue to work on all variants…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609779087","repostId":"1134775339","repostType":2,"repost":{"id":"1134775339","kind":"news","pubTimestamp":1638325598,"share":"https://www.laohu8.com/m/news/1134775339?lang=&edition=full","pubTime":"2021-12-01 10:26","market":"us","language":"en","title":"Is a Stock Market Correction Coming? Here’s a Big Red Flag","url":"https://stock-news.laohu8.com/highlight/detail?id=1134775339","media":"Barrons","summary":"To say that the Omicron variant is shaking the market would be an understatement. But add that stock","content":"<p>To say that the Omicron variant is shaking the market would be an understatement. But add that stocks are more expensive than they’ve ever been—and a true correction now wouldn’t surprise anybody.</p>\n<p>The S&amp;P 500 has fallen almost 3% from its all-time high hit in late November, just before scientists in South Africa reported the new Covid-19 strain. On Friday, the market had its worst day of the year. Tuesday was more ugliness—producers of vaccines and treatments predicted their remedies probably wouldn’t be as effective against Omicron as other variants.</p>\n<p>But that true correction—a 10% drop—has been elusive, even during all these months of the pandemic. And that itself is a bit astonishing, since corrections are often a normal part of a larger bull market.</p>\n<p>One indicator, though, forecasts a correction—like a dark cloud usually brings rain. The total U.S. equity market capitalization is about 215% of U.S. gross domestic product—the highest level ever, according to Global Financial Data.</p>\n<p>Such a high number isn’t good. It’s bad, often a sign that a correction is just around the corner</p>\n<p>In 1929, market cap to GDP hit an all-time high of about 100%, just before the famous stock market crash late that year. In 2000, another high at about 150%, just before a bear market—a drop of at least 20%—began. In 2008, a multiyear high, just ahead of the financial crisis.</p>\n<p>The upshot: Maybe a correction; then again, maybe not. It’s all in the hands of investors.</p>\n<p>To be sure, stock valuations aren’t known to be the best timing tool for investors deciding if they should do more buying or selling. Valuations can stay high for a long time.</p>\n<p>For most of the pandemic era, in fact, the market has been valued at its highest level relative to GDP ever. But high valuations do indicate that when—and if—the economic outlook really does deteriorate, stocks can fall really hard.</p>\n<p>“There is certainly the potential for additional market drops and heightened volatility in coming weeks as a result of this variant, especially given all the uncertainty surrounding it,” wrote Kristina Hooper, chief global market strategist at Invesco. “There is room for a decent correction.”</p>\n<p>What the market needs now is a little hope—that vaccines will be effective against the new variant. Otherwise, get ready for a correction.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is a Stock Market Correction Coming? Here’s a Big Red Flag</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs a Stock Market Correction Coming? Here’s a Big Red Flag\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/stock-market-correction-51638305804?mod=newsviewer_click_seemore><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>To say that the Omicron variant is shaking the market would be an understatement. But add that stocks are more expensive than they’ve ever been—and a true correction now wouldn’t surprise anybody.\nThe...</p>\n\n<a href=\"https://www.marketwatch.com/articles/stock-market-correction-51638305804?mod=newsviewer_click_seemore\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/articles/stock-market-correction-51638305804?mod=newsviewer_click_seemore","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1134775339","content_text":"To say that the Omicron variant is shaking the market would be an understatement. But add that stocks are more expensive than they’ve ever been—and a true correction now wouldn’t surprise anybody.\nThe S&P 500 has fallen almost 3% from its all-time high hit in late November, just before scientists in South Africa reported the new Covid-19 strain. On Friday, the market had its worst day of the year. Tuesday was more ugliness—producers of vaccines and treatments predicted their remedies probably wouldn’t be as effective against Omicron as other variants.\nBut that true correction—a 10% drop—has been elusive, even during all these months of the pandemic. And that itself is a bit astonishing, since corrections are often a normal part of a larger bull market.\nOne indicator, though, forecasts a correction—like a dark cloud usually brings rain. The total U.S. equity market capitalization is about 215% of U.S. gross domestic product—the highest level ever, according to Global Financial Data.\nSuch a high number isn’t good. It’s bad, often a sign that a correction is just around the corner\nIn 1929, market cap to GDP hit an all-time high of about 100%, just before the famous stock market crash late that year. In 2000, another high at about 150%, just before a bear market—a drop of at least 20%—began. In 2008, a multiyear high, just ahead of the financial crisis.\nThe upshot: Maybe a correction; then again, maybe not. It’s all in the hands of investors.\nTo be sure, stock valuations aren’t known to be the best timing tool for investors deciding if they should do more buying or selling. Valuations can stay high for a long time.\nFor most of the pandemic era, in fact, the market has been valued at its highest level relative to GDP ever. But high valuations do indicate that when—and if—the economic outlook really does deteriorate, stocks can fall really hard.\n“There is certainly the potential for additional market drops and heightened volatility in coming weeks as a result of this variant, especially given all the uncertainty surrounding it,” wrote Kristina Hooper, chief global market strategist at Invesco. “There is room for a decent correction.”\nWhat the market needs now is a little hope—that vaccines will be effective against the new variant. Otherwise, get ready for a correction.","news_type":1},"isVote":1,"tweetType":1,"viewCount":906,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874183713,"gmtCreate":1637743910331,"gmtModify":1637743910331,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Bought some for long terms gain… 😄","listText":"Bought some for long terms gain… 😄","text":"Bought some for long terms gain… 😄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874183713","repostId":"2185804343","repostType":2,"isVote":1,"tweetType":1,"viewCount":865,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875628055,"gmtCreate":1637646197373,"gmtModify":1637646200152,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Hmmm… both","listText":"Hmmm… both","text":"Hmmm… both","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875628055","repostId":"1107351089","repostType":4,"repost":{"id":"1107351089","kind":"news","pubTimestamp":1637623277,"share":"https://www.laohu8.com/m/news/1107351089?lang=&edition=full","pubTime":"2021-11-23 07:21","market":"us","language":"en","title":"Nvidia or AMD: Which Stock Is the Better Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=1107351089","media":"TheStreet","summary":"Semiconductor stocks have been on fire this year. NVDA and AMD are among the most popular stocks on ","content":"<p>Semiconductor stocks have been on fire this year. NVDA and AMD are among the most popular stocks on the main Reddit forums – but which is a better pick?</p>\n<p>The semiconductor industry has been under “bullish attack” in 2021. The iShares Semiconductor ETF(<b>SOXX</b>)&nbsp;is up more than 50% in the past year, with two of the most relevant players in the sector competing for the spotlight: NVIDIA&nbsp;and Advanced Micro Devices(<b>AMD</b>).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3401b1f213322e232b5914c45385c546\" tg-width=\"687\" tg-height=\"625\" width=\"100%\" height=\"auto\"><span>Figure 1: NVDA, AMD and SOXX price chart over 1-year period.</span></p>\n<p>The rally has been fueled by several catalysts: sustainable revenue growth with long-term opportunities in areas like games, EV and the metaverse; rich gross margins; and strong balance sheets. Today, we look at NVIDIA and AMD stocks and ask the question: which of these two is a better buy at current levels?</p>\n<p><b>NVDA stock according to Wall Street</b></p>\n<p>NVDA has a consensus strong buy rating by Wall Street experts, based on 24 reports released in the past 3 months. The average price target on the stock is $356, which represents very modest 8% upside potential from current levels.</p>\n<p>The chip company announced Q3 results on November 17. Since then, analysts have reinforced their bullishness as the stock surged another 12% after earnings.</p>\n<ul>\n <li>Bank of America analyst Vivek Arya&nbsp;raised&nbsp;the company’s price target to $375.00 from $340.00 after earnings, pointing at 14% upside potential. The analyst sees NVDA’s having a unique combination of “highly leverageable silicon, software, scale and systems expertise” that will continue to position it at the forefront of some of the largest and fastest growth markets in tech.</li>\n</ul>\n<ul>\n <li>Craig-Hallum analyst Richard Shannon also&nbsp;raised&nbsp;NVDA’s price target after earnings to $350 from $220, suggesting modest gain opportunity of 6%. While he keeps a buy rating on the shares, he also suspects that the gaming cycle has hit its peak. Still, the analyst is raising estimates as nothing seems to be slowing NVIDIA in the data center.</li>\n</ul>\n<ul>\n <li>Susquehanna analyst Christopher Rolland&nbsp;reiterated&nbsp;his buy recommendation on NVDA after earnings, forecasting a 9% upside potential. The analyst sees data center as the star of the show, and he expects to see even more growth in 4Q.</li>\n</ul>\n<p><b>AMD stock according to Wall Street</b></p>\n<p>Analysts are also bullish on AMD stock, based on 22 recent reports. But the recommendation, in this case, is only a “moderate buy” and the $142 average price target counterintuitively represents 9% downside potential. AMD share price has probably run to fast for Wall Street to catch up.</p>\n<ul>\n <li>Wedbush analyst Matt Bryson&nbsp;maintained&nbsp;a buy recommendation a few days ago and raised AMD’s price target to $165 for mid-single digit upside potential. According to the analyst, \"so as long as AMD executes,\" the company should be able to gain share over the mid-term to fuel growth over the next few years. Mr. Bryson also mentioned AMD's data center, which makes him more confident in the thesis.</li>\n</ul>\n<ul>\n <li>Goldman Sachs’ Toshiya Hari, also an AMD bull,raised&nbsp;the share price target to $170. The analyst seemed surprised by the Meta/Facebook design win since the company has historically been a loyal user of Intel processors. The expert is also encouraged by the company's updated server CPU product pipeline. In the end, AMD should grow market share, margins, EPS, and FCF beyond what Wall Street has been modeling, according to Goldman.</li>\n</ul>\n<ul>\n <li>Jefferies analyst Mark Lipacis is another one with a buy&nbsp;recommendation&nbsp;on AMD, but his $145 price target on the stock represents downside risk of 7%. The analyst’s bull case relies on Meta Platforms being a huge deal win for AMD to accelerate market share gains.</li>\n</ul>\n<p><b>Wall Street Memes’ take</b></p>\n<p>The fundamentals of both NVDA and AMD appear to be as strong as ever. Accelerated growth in the core business segments and upbeat outlook should appeal to growth investors. However, such expectations for future financial results could be valuing NVDA and AMD at too rich a multiple.</p>\n<p>NVDA, for instance, trades at a current P/E ratio of 74 times – the second highest multiple among the 20 largest companies by market cap, only trailing Tesla TSLA). AMD, valued at a slightly lower P/E ratio of 64 times, cannot be considered a bargain either.</p>\n<p>More easily than finding many fundamental differences between NVDA and AMD, we see more similarities between the stocks. Both companies should attract growth investors who think that the long-term opportunities in tech might be underappreciated today. The more value-conscious investor, however, will probably be discouraged by the valuation multiples in both cases.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia or AMD: Which Stock Is the Better Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia or AMD: Which Stock Is the Better Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-23 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/memestocks/reddit-trends/nvidia-or-amd-stock-which-is-a-better-buy-now><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Semiconductor stocks have been on fire this year. NVDA and AMD are among the most popular stocks on the main Reddit forums – but which is a better pick?\nThe semiconductor industry has been under “...</p>\n\n<a href=\"https://www.thestreet.com/memestocks/reddit-trends/nvidia-or-amd-stock-which-is-a-better-buy-now\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司","NVDA":"英伟达"},"source_url":"https://www.thestreet.com/memestocks/reddit-trends/nvidia-or-amd-stock-which-is-a-better-buy-now","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107351089","content_text":"Semiconductor stocks have been on fire this year. NVDA and AMD are among the most popular stocks on the main Reddit forums – but which is a better pick?\nThe semiconductor industry has been under “bullish attack” in 2021. The iShares Semiconductor ETF(SOXX) is up more than 50% in the past year, with two of the most relevant players in the sector competing for the spotlight: NVIDIA and Advanced Micro Devices(AMD).\nFigure 1: NVDA, AMD and SOXX price chart over 1-year period.\nThe rally has been fueled by several catalysts: sustainable revenue growth with long-term opportunities in areas like games, EV and the metaverse; rich gross margins; and strong balance sheets. Today, we look at NVIDIA and AMD stocks and ask the question: which of these two is a better buy at current levels?\nNVDA stock according to Wall Street\nNVDA has a consensus strong buy rating by Wall Street experts, based on 24 reports released in the past 3 months. The average price target on the stock is $356, which represents very modest 8% upside potential from current levels.\nThe chip company announced Q3 results on November 17. Since then, analysts have reinforced their bullishness as the stock surged another 12% after earnings.\n\nBank of America analyst Vivek Arya raised the company’s price target to $375.00 from $340.00 after earnings, pointing at 14% upside potential. The analyst sees NVDA’s having a unique combination of “highly leverageable silicon, software, scale and systems expertise” that will continue to position it at the forefront of some of the largest and fastest growth markets in tech.\n\n\nCraig-Hallum analyst Richard Shannon also raised NVDA’s price target after earnings to $350 from $220, suggesting modest gain opportunity of 6%. While he keeps a buy rating on the shares, he also suspects that the gaming cycle has hit its peak. Still, the analyst is raising estimates as nothing seems to be slowing NVIDIA in the data center.\n\n\nSusquehanna analyst Christopher Rolland reiterated his buy recommendation on NVDA after earnings, forecasting a 9% upside potential. The analyst sees data center as the star of the show, and he expects to see even more growth in 4Q.\n\nAMD stock according to Wall Street\nAnalysts are also bullish on AMD stock, based on 22 recent reports. But the recommendation, in this case, is only a “moderate buy” and the $142 average price target counterintuitively represents 9% downside potential. AMD share price has probably run to fast for Wall Street to catch up.\n\nWedbush analyst Matt Bryson maintained a buy recommendation a few days ago and raised AMD’s price target to $165 for mid-single digit upside potential. According to the analyst, \"so as long as AMD executes,\" the company should be able to gain share over the mid-term to fuel growth over the next few years. Mr. Bryson also mentioned AMD's data center, which makes him more confident in the thesis.\n\n\nGoldman Sachs’ Toshiya Hari, also an AMD bull,raised the share price target to $170. The analyst seemed surprised by the Meta/Facebook design win since the company has historically been a loyal user of Intel processors. The expert is also encouraged by the company's updated server CPU product pipeline. In the end, AMD should grow market share, margins, EPS, and FCF beyond what Wall Street has been modeling, according to Goldman.\n\n\nJefferies analyst Mark Lipacis is another one with a buy recommendation on AMD, but his $145 price target on the stock represents downside risk of 7%. The analyst’s bull case relies on Meta Platforms being a huge deal win for AMD to accelerate market share gains.\n\nWall Street Memes’ take\nThe fundamentals of both NVDA and AMD appear to be as strong as ever. Accelerated growth in the core business segments and upbeat outlook should appeal to growth investors. However, such expectations for future financial results could be valuing NVDA and AMD at too rich a multiple.\nNVDA, for instance, trades at a current P/E ratio of 74 times – the second highest multiple among the 20 largest companies by market cap, only trailing Tesla TSLA). AMD, valued at a slightly lower P/E ratio of 64 times, cannot be considered a bargain either.\nMore easily than finding many fundamental differences between NVDA and AMD, we see more similarities between the stocks. Both companies should attract growth investors who think that the long-term opportunities in tech might be underappreciated today. The more value-conscious investor, however, will probably be discouraged by the valuation multiples in both cases.","news_type":1},"isVote":1,"tweetType":1,"viewCount":669,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844218737,"gmtCreate":1636429829281,"gmtModify":1636430056505,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>Up up all the way 😄","listText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>Up up all the way 😄","text":"$Lucid Group Inc(LCID)$Up up all the way 😄","images":[{"img":"https://static.tigerbbs.com/6d051f1bdcdd23ae132420f6f7bf3c8d","width":"1125","height":"2710"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844218737","isVote":1,"tweetType":1,"viewCount":714,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"hots":[{"id":606181174,"gmtCreate":1638842955281,"gmtModify":1638842955385,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098678914535810","idStr":"4098678914535810"},"themes":[],"htmlText":"Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️","listText":"Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️","text":"Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606181174","repostId":"1165217690","repostType":2,"repost":{"id":"1165217690","kind":"news","pubTimestamp":1638841605,"share":"https://www.laohu8.com/m/news/1165217690?lang=&edition=full","pubTime":"2021-12-07 09:46","market":"us","language":"en","title":"Vaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1165217690","media":"InvestorPlace","summary":"Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactl","content":"<p>Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactly why. After more than a week of ominous reports on the omicron virus and mounting speculation about its severity, yesterday brought some welcome news. Dr. Anthony Fauci, White House chief medical officer and a trusted expert on the virus, stated yesterday that some clear preliminary data was finally starting to emerge on the severity of the new variant and that so far, the results looked“encouraging.”</p>\n<p>What’s Happening With Vaccine Stocks</p>\n<p>Since news of the new variant first began dominating media airwaves, vaccine producers have been scrambling to be the first to address the new Covid-19 strain that threatened to undo the work that sent their stocks up earlier this year. Today has seen all the prominent names among vaccine stocks plunge across the board. While this isn’t strictly due to Dr. Fauci’s comments, it’s possible that the demand for new vaccine innovations and treatments may not be as great as we feared only a few days ago.</p>\n<p><b>BioNTech</b>&nbsp;(NASDAQ:<b><u>BNTX</u></b>) has suffered the worst declines of the day among vaccine stocks, with shares down almost 19% as of this writing. Next in line is&nbsp;<b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>), which has fallen more than 13%. Then,&nbsp;<b>Novavax’s</b>(NASDAQ:<b><u>NVAX</u></b>)declines come in just shy of 12%. Rounding out the pack is&nbsp;<b>Pfizer</b>(NYSE:<b><u>PFE</u></b>), which is in the red by just over 5% as trading winds to a close today.</p>\n<p>Why It Matters</p>\n<p>The clearest indication we should take from today’s events is that market mentality is shifting. This is evidenced by the performances we’ve seen not just from vaccine stocks but from other sectors that were differently affected by the spreading variant news. As&nbsp;<i>InvestorPlace’</i>s Shrey Dua reports,&nbsp;cruise ship stocks&nbsp;such as&nbsp;<b>Royal Caribbean</b>(NYSE:<b><u>RCL</u></b>) and&nbsp;<b>Carnival</b>(NYSE:<b><u>CCL</u></b>) are back in the green today after a troubling week of variant concerns. The same can be said for airline stocks, as names such as&nbsp;<b>Delta</b>&nbsp;(NYSE:<b><u>DAL</u></b>) and&nbsp;<b>Southwest</b>&nbsp;(NYSE:<b><u>LUV</u></b>) have gained some altitude today.</p>\n<p>Of course, it’s too soon to tell what the future will look like. The preliminary results upon which Dr. Fauci commented are exactly that — preliminary. Scientists and medical researchers still have plenty of research to do before they will be able outline a bigger picture. Dr. Fauci was careful to add that while there does not seem to be a “great degree of severity” to the spreading variant, it is still too early for any definitive conclusions to be reached. Omicron is still very much a variant of concern.</p>\n<p>What It Means</p>\n<p>Even if the variant does not end up posing as serious a threat to highly vaccinated countries as has been speculated, the need for vaccines isn’t going to go away. Fear of the variant has spiked&nbsp;demand&nbsp;for vaccinations in the U.S., and many countries are still struggling to get more of their populations partially or fully vaccinated. The industry landscape may not end up looking quite as bleak close to home as some of us have feared. However, that doesn’t mean that the demand for vaccines won’t be increasing throughout the months ahead.</p>\n<p>This news certainly doesn’t mean that a bearish play on vaccine stocks is advisable. Far from it, in fact. Novavax has an&nbsp;important catalyst&nbsp;rapidly approaching as the World Health Organization (WHO) considers granting it emergency use authorization. More than likely, vaccine stocks will be quick to rebound.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 09:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/vaccine-stocks-why-mrna-bntx-nvax-pfe-stocks-are-stumbling-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactly why. After more than a week of ominous reports on the omicron virus and mounting speculation about...</p>\n\n<a href=\"https://investorplace.com/2021/12/vaccine-stocks-why-mrna-bntx-nvax-pfe-stocks-are-stumbling-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://investorplace.com/2021/12/vaccine-stocks-why-mrna-bntx-nvax-pfe-stocks-are-stumbling-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165217690","content_text":"Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactly why. After more than a week of ominous reports on the omicron virus and mounting speculation about its severity, yesterday brought some welcome news. Dr. Anthony Fauci, White House chief medical officer and a trusted expert on the virus, stated yesterday that some clear preliminary data was finally starting to emerge on the severity of the new variant and that so far, the results looked“encouraging.”\nWhat’s Happening With Vaccine Stocks\nSince news of the new variant first began dominating media airwaves, vaccine producers have been scrambling to be the first to address the new Covid-19 strain that threatened to undo the work that sent their stocks up earlier this year. Today has seen all the prominent names among vaccine stocks plunge across the board. While this isn’t strictly due to Dr. Fauci’s comments, it’s possible that the demand for new vaccine innovations and treatments may not be as great as we feared only a few days ago.\nBioNTech (NASDAQ:BNTX) has suffered the worst declines of the day among vaccine stocks, with shares down almost 19% as of this writing. Next in line is Moderna(NASDAQ:MRNA), which has fallen more than 13%. Then, Novavax’s(NASDAQ:NVAX)declines come in just shy of 12%. Rounding out the pack is Pfizer(NYSE:PFE), which is in the red by just over 5% as trading winds to a close today.\nWhy It Matters\nThe clearest indication we should take from today’s events is that market mentality is shifting. This is evidenced by the performances we’ve seen not just from vaccine stocks but from other sectors that were differently affected by the spreading variant news. As InvestorPlace’s Shrey Dua reports, cruise ship stocks such as Royal Caribbean(NYSE:RCL) and Carnival(NYSE:CCL) are back in the green today after a troubling week of variant concerns. The same can be said for airline stocks, as names such as Delta (NYSE:DAL) and Southwest (NYSE:LUV) have gained some altitude today.\nOf course, it’s too soon to tell what the future will look like. The preliminary results upon which Dr. Fauci commented are exactly that — preliminary. Scientists and medical researchers still have plenty of research to do before they will be able outline a bigger picture. Dr. Fauci was careful to add that while there does not seem to be a “great degree of severity” to the spreading variant, it is still too early for any definitive conclusions to be reached. Omicron is still very much a variant of concern.\nWhat It Means\nEven if the variant does not end up posing as serious a threat to highly vaccinated countries as has been speculated, the need for vaccines isn’t going to go away. Fear of the variant has spiked demand for vaccinations in the U.S., and many countries are still struggling to get more of their populations partially or fully vaccinated. The industry landscape may not end up looking quite as bleak close to home as some of us have feared. However, that doesn’t mean that the demand for vaccines won’t be increasing throughout the months ahead.\nThis news certainly doesn’t mean that a bearish play on vaccine stocks is advisable. Far from it, in fact. Novavax has an important catalyst rapidly approaching as the World Health Organization (WHO) considers granting it emergency use authorization. More than likely, vaccine stocks will be quick to rebound.","news_type":1},"isVote":1,"tweetType":1,"viewCount":678,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603626872,"gmtCreate":1638407150732,"gmtModify":1638407150803,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098678914535810","idStr":"4098678914535810"},"themes":[],"htmlText":"Heal the world…. Make it a better place😊","listText":"Heal the world…. Make it a better place😊","text":"Heal the world…. Make it a better place😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/603626872","repostId":"1196358645","repostType":4,"isVote":1,"tweetType":1,"viewCount":773,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604441479,"gmtCreate":1639441708814,"gmtModify":1639441708882,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098678914535810","idStr":"4098678914535810"},"themes":[],"htmlText":"Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄","listText":"Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄","text":"Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604441479","repostId":"1133455327","repostType":4,"repost":{"id":"1133455327","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406792,"share":"https://www.laohu8.com/m/news/1133455327?lang=&edition=full","pubTime":"2021-12-13 22:46","market":"us","language":"en","title":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133455327","media":"Tiger Newspress","summary":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping ove","content":"<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133455327","content_text":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.\nA new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.","news_type":1},"isVote":1,"tweetType":1,"viewCount":466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608007502,"gmtCreate":1638578434765,"gmtModify":1638578434765,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098678914535810","idStr":"4098678914535810"},"themes":[],"htmlText":"Heal the world…make it a better place☘️☘️☘️","listText":"Heal the world…make it a better place☘️☘️☘️","text":"Heal the world…make it a better place☘️☘️☘️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608007502","repostId":"1177965649","repostType":2,"repost":{"id":"1177965649","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638575220,"share":"https://www.laohu8.com/m/news/1177965649?lang=&edition=full","pubTime":"2021-12-04 07:47","market":"fut","language":"zh","title":"昨夜今晨：血崩！美股市场巨震，中概股再遭重击","url":"https://stock-news.laohu8.com/highlight/detail?id=1177965649","media":"老虎资讯综合","summary":"摘要：非农数据引发市场巨震，纳指大跌近2%；热门中概股集体大跌，滴滴跌逾22%；美国总统拜登正式签署短期支出法案，政府运营将持续到明年2月；IMF总裁预期全球经济增速将被下调>>>\n\n收盘：非农数据远","content":"<blockquote>\n <b>摘要：</b>非农数据引发市场巨震，纳指大跌近2%；热门中概股集体大跌，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>跌逾22%；美国总统拜登正式签署短期支出法案，政府运营将持续到明年2月；IMF总裁预期全球经济增速将被下调&gt;&gt;&gt;\n</blockquote>\n<p><b>收盘：非农数据远逊预期 美股周五收跌</b></p>\n<p>美东时间周五，对奥密克戎变异毒株的担忧情绪仍然主导市场，加上11月非农数据远逊预期，三大指数集体收跌，科技股遭到普遍抛售，纳指盘中一度跌超2.5%。截至收盘，道琼斯指数跌0.17%，报34,580.08点；标普500指数跌0.84%，报4,538.43点；纳斯达克指数跌1.92%，报15,085.50点。</p>\n<p><b>热门中概股普遍下挫，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>跌逾22%</b></p>\n<p>热门中概股集体大跌，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>跌8.23%，<a href=\"https://laohu8.com/S/JD\">京东</a>跌7.71%，微博跌6.34%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>跌8.16%，<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>跌7.15%，<a href=\"https://laohu8.com/S/BIDU\">百度</a>跌7.77%，<a href=\"https://laohu8.com/S/EDU\">新东方</a>跌9.22%，<a href=\"https://laohu8.com/S/NTES\">网易</a>跌6.90%，<a href=\"https://laohu8.com/S/TME\">腾讯音乐</a>跌11.94%，<a href=\"https://laohu8.com/S/IQ\">爱奇艺</a>跌15.74%，滴滴跌22.18%。</p>\n<p><b>本周美国WTI原油下跌2.8% 连续第六周录得跌幅</b></p>\n<p>美国原油期货价格丧失了周五早盘的涨幅，最终逆转收跌。该期货连续第六周录得跌幅。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格下跌24美分，跌幅0.4%，收于每桶66.26美元，盘中最高曾达到69.22美元。根据FactSet的数据，按照最活跃合约计算，本周WTI原油期货价格下跌2.8%，为连续第六周录得跌幅。</p>\n<p><b>黄金期货价格周五收高1.2% 本周下跌0.1%</b></p>\n<p>黄金期货价格周五收高，保住了美国11月非农就业数据公布后所获大部分涨幅。但本周金价录得跌幅。纽约商品交易所交投最活跃的2月黄金期货价格上涨21.20美元，涨幅1.2%，收于每盎司1783.90美元。本周黄金期货价格下跌近0.1%。</p>\n<p><b>欧股主要指数下跌，德国DAX30指数收跌0.7%</b></p>\n<p>德国DAX30指数周五收跌0.71%，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>指数跌0.14%，法国CAC40指数跌0.44%，欧洲斯托克50指数跌0.70%，西班牙IBEX35指数跌0.76%，意大利富时MIB指数跌0.27%。</p>\n<p><b>国际宏观</b></p>\n<p><a href=\"https://laohu8.com/NW/2188264524\" target=\"_blank\"><b>美国11月非农报告耐人寻味 新增就业年内最低但失业率下降</b></a></p>\n<p>美国11月非农就业人数录得今年最小增幅，失业率超预期降至4.2%，虽然这些数据看起来喜忧参半，但仍可能推动美联储加快撤出疫情期间的货币刺激措施。美国劳工部周五公布的数据显示，11月非农就人数增长21万，此前两个月的数据都被向上调整。劳动力参与率微升至61.8%。</p>\n<p><a href=\"https://laohu8.com/NW/2188520783\" target=\"_blank\"><b>IMF总裁预期全球经济增速将被下调 受omicron变种影响</b></a></p>\n<p>国际货币基金组织（IMF）总裁格奥尔基耶娃预计，随着omicron变异毒株的病例数量增加，该组织将削减对全球经济反弹的预期。“我们可能会下调10月份时对全球经济增长的一些预测，”格奥尔基耶娃周五在路透主办的会议上表示。她说，新的变异毒株“可能很快就会削弱信心”。</p>\n<p><a href=\"https://laohu8.com/NW/2188520361\" target=\"_blank\"><b>美国总统拜登正式签署短期支出法案 政府运营将持续到明年2月</b></a></p>\n<p>美国总统拜登当地时间12月3日正式签署了短期支出法案，避免了政府的停摆危机。然而，短期支出法案只能维持政府运营持续到2月18日，国会议员们依然需要在明年年初制定另一项拨款法案。</p>\n<p><a href=\"https://laohu8.com/NW/2188527747\" target=\"_blank\"><b>IMF喊话美联储：重视通胀风险 尽快加速taper</b></a></p>\n<p>国际货币基金组织（IMF）警告称，鉴于美国通胀风险上升，并且奥密克戎变异毒株造成了新的不确定性，美联储官员应加快收紧货币政策的步伐。IMF首席经济学家Gita Gopinath和货币与资本市场部门主管Tobias Adrian撰文称，新冠疫情的复苏以及奥密克戎变异毒株的蔓延大大增加了全球经济的不确定性。</p>\n<p><b>公司新闻</b></p>\n<p><b><a href=\"https://laohu8.com/S/MRK\">默沙东</a>将向加拿大提供至多100万疗程新冠药物</b></p>\n<p><a href=\"https://laohu8.com/S/MRK\">默沙东</a>周五表示，将向加拿大提供至多100万疗程的新冠口服药物molnupiravir。据悉，加拿大政府已确保将在2022年采购50万疗程的molnupiravir，剩下50万疗程正等待加拿大卫生部的批准。</p>\n<p><b><a href=\"https://laohu8.com/S/GOOG\">谷歌</a>和梅塔公司将再度面临被俄罗斯一法院罚款</b></p>\n<p>据媒体报道，俄罗斯首都莫斯科塔甘斯基第422号地方法院将于12月24日举行听证会，审理由俄联邦电信、信息技术和大众传媒监督局提交的<a href=\"https://laohu8.com/S/GOOG\">谷歌</a>和梅塔公司（原脸书公司）行政犯罪的记录。上述公司没有按照规定删除被俄罗斯官方禁止传播的信息和内容，或将面临最高达其年收入总额十分之一的罚款。</p>\n<p><b>福特目标在两年内成为全球第二大电动车销售商</b></p>\n<p>当地时间周五，<a href=\"https://laohu8.com/S/F\">福特汽车</a>首席运营官Lisa Drake表示，福特预计将在两年内成为全球第二大电动汽车销售商，年产量接近60万辆，仅次于<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>。据分析师预估，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>有望在2021年销售89万辆汽车。</p>\n<p><b>传<a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>考虑将新疫苗部门上市</b></p>\n<p>据媒体援引消息人士称，<a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>可能将其新成立的疫苗部门上市，以提高投资者的回报。知情人士透露，关于新疫苗部门上市的设想，阿斯利康仍处在早期阶段，公司高层已与顾问讨论了一系列可能性。</p>\n<p><b>推特调整高管团队</b></p>\n<p>据媒体周五报道，推特公司在一份监管文件中表示，负责推特设计和研究的Dantley Davis和工程主管Michael Montano将离开公司。推特表示，这些举措旨在提高问责、速度和运营效率。本周早些时候，推特联合创始人Jack Dorsey宣布辞去CEO一职。</p>\n<p><a href=\"https://laohu8.com/NW/2188200520\" target=\"_blank\"><b>加拿大鹅遭炮轰 股价创2020年3月以来最大周跌幅</b></a></p>\n<p><a href=\"https://laohu8.com/S/GOOS\">加拿大鹅</a>股价本周一度下跌21%，创下2020年3月以来的最差单周表现。近日，加拿大鹅品牌“不得退换”的“霸王条款”引发舆论热议。数据显示，该公司财年第二季度约25%的收入来自亚洲。</p>\n<p><a href=\"https://laohu8.com/NW/2188224515\" target=\"_blank\"><b>BioNTech首席执行官：公司有能力迅速推出针对Omicron的疫苗</b></a></p>\n<p>BioNTech首席执行官Ugur Sahin接受采访时表示，在奥密克戎变异病毒出现后，公司有能力迅速调整其新冠病毒疫苗以针对新变异体。Sahin表示：“我原则上相信，在某个特定的时间点，我们将需要一种专门针对这类变异病毒的新疫苗，但问题是需求是否像去年那样非常迫切。”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>昨夜今晨：血崩！美股市场巨震，中概股再遭重击</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n昨夜今晨：血崩！美股市场巨震，中概股再遭重击\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-04 07:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n <b>摘要：</b>非农数据引发市场巨震，纳指大跌近2%；热门中概股集体大跌，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>跌逾22%；美国总统拜登正式签署短期支出法案，政府运营将持续到明年2月；IMF总裁预期全球经济增速将被下调&gt;&gt;&gt;\n</blockquote>\n<p><b>收盘：非农数据远逊预期 美股周五收跌</b></p>\n<p>美东时间周五，对奥密克戎变异毒株的担忧情绪仍然主导市场，加上11月非农数据远逊预期，三大指数集体收跌，科技股遭到普遍抛售，纳指盘中一度跌超2.5%。截至收盘，道琼斯指数跌0.17%，报34,580.08点；标普500指数跌0.84%，报4,538.43点；纳斯达克指数跌1.92%，报15,085.50点。</p>\n<p><b>热门中概股普遍下挫，<a href=\"https://laohu8.com/S/DIDI\">滴滴</a>跌逾22%</b></p>\n<p>热门中概股集体大跌，<a href=\"https://laohu8.com/S/BABA\">阿里巴巴</a>跌8.23%，<a href=\"https://laohu8.com/S/JD\">京东</a>跌7.71%，微博跌6.34%，<a href=\"https://laohu8.com/S/PDD\">拼多多</a>跌8.16%，<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>跌7.15%，<a href=\"https://laohu8.com/S/BIDU\">百度</a>跌7.77%，<a href=\"https://laohu8.com/S/EDU\">新东方</a>跌9.22%，<a href=\"https://laohu8.com/S/NTES\">网易</a>跌6.90%，<a href=\"https://laohu8.com/S/TME\">腾讯音乐</a>跌11.94%，<a href=\"https://laohu8.com/S/IQ\">爱奇艺</a>跌15.74%，滴滴跌22.18%。</p>\n<p><b>本周美国WTI原油下跌2.8% 连续第六周录得跌幅</b></p>\n<p>美国原油期货价格丧失了周五早盘的涨幅，最终逆转收跌。该期货连续第六周录得跌幅。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格下跌24美分，跌幅0.4%，收于每桶66.26美元，盘中最高曾达到69.22美元。根据FactSet的数据，按照最活跃合约计算，本周WTI原油期货价格下跌2.8%，为连续第六周录得跌幅。</p>\n<p><b>黄金期货价格周五收高1.2% 本周下跌0.1%</b></p>\n<p>黄金期货价格周五收高，保住了美国11月非农就业数据公布后所获大部分涨幅。但本周金价录得跌幅。纽约商品交易所交投最活跃的2月黄金期货价格上涨21.20美元，涨幅1.2%，收于每盎司1783.90美元。本周黄金期货价格下跌近0.1%。</p>\n<p><b>欧股主要指数下跌，德国DAX30指数收跌0.7%</b></p>\n<p>德国DAX30指数周五收跌0.71%，<a href=\"https://laohu8.com/S/VUKE.UK\">英国富时100</a>指数跌0.14%，法国CAC40指数跌0.44%，欧洲斯托克50指数跌0.70%，西班牙IBEX35指数跌0.76%，意大利富时MIB指数跌0.27%。</p>\n<p><b>国际宏观</b></p>\n<p><a href=\"https://laohu8.com/NW/2188264524\" target=\"_blank\"><b>美国11月非农报告耐人寻味 新增就业年内最低但失业率下降</b></a></p>\n<p>美国11月非农就业人数录得今年最小增幅，失业率超预期降至4.2%，虽然这些数据看起来喜忧参半，但仍可能推动美联储加快撤出疫情期间的货币刺激措施。美国劳工部周五公布的数据显示，11月非农就人数增长21万，此前两个月的数据都被向上调整。劳动力参与率微升至61.8%。</p>\n<p><a href=\"https://laohu8.com/NW/2188520783\" target=\"_blank\"><b>IMF总裁预期全球经济增速将被下调 受omicron变种影响</b></a></p>\n<p>国际货币基金组织（IMF）总裁格奥尔基耶娃预计，随着omicron变异毒株的病例数量增加，该组织将削减对全球经济反弹的预期。“我们可能会下调10月份时对全球经济增长的一些预测，”格奥尔基耶娃周五在路透主办的会议上表示。她说，新的变异毒株“可能很快就会削弱信心”。</p>\n<p><a href=\"https://laohu8.com/NW/2188520361\" target=\"_blank\"><b>美国总统拜登正式签署短期支出法案 政府运营将持续到明年2月</b></a></p>\n<p>美国总统拜登当地时间12月3日正式签署了短期支出法案，避免了政府的停摆危机。然而，短期支出法案只能维持政府运营持续到2月18日，国会议员们依然需要在明年年初制定另一项拨款法案。</p>\n<p><a href=\"https://laohu8.com/NW/2188527747\" target=\"_blank\"><b>IMF喊话美联储：重视通胀风险 尽快加速taper</b></a></p>\n<p>国际货币基金组织（IMF）警告称，鉴于美国通胀风险上升，并且奥密克戎变异毒株造成了新的不确定性，美联储官员应加快收紧货币政策的步伐。IMF首席经济学家Gita Gopinath和货币与资本市场部门主管Tobias Adrian撰文称，新冠疫情的复苏以及奥密克戎变异毒株的蔓延大大增加了全球经济的不确定性。</p>\n<p><b>公司新闻</b></p>\n<p><b><a href=\"https://laohu8.com/S/MRK\">默沙东</a>将向加拿大提供至多100万疗程新冠药物</b></p>\n<p><a href=\"https://laohu8.com/S/MRK\">默沙东</a>周五表示，将向加拿大提供至多100万疗程的新冠口服药物molnupiravir。据悉，加拿大政府已确保将在2022年采购50万疗程的molnupiravir，剩下50万疗程正等待加拿大卫生部的批准。</p>\n<p><b><a href=\"https://laohu8.com/S/GOOG\">谷歌</a>和梅塔公司将再度面临被俄罗斯一法院罚款</b></p>\n<p>据媒体报道，俄罗斯首都莫斯科塔甘斯基第422号地方法院将于12月24日举行听证会，审理由俄联邦电信、信息技术和大众传媒监督局提交的<a href=\"https://laohu8.com/S/GOOG\">谷歌</a>和梅塔公司（原脸书公司）行政犯罪的记录。上述公司没有按照规定删除被俄罗斯官方禁止传播的信息和内容，或将面临最高达其年收入总额十分之一的罚款。</p>\n<p><b>福特目标在两年内成为全球第二大电动车销售商</b></p>\n<p>当地时间周五，<a href=\"https://laohu8.com/S/F\">福特汽车</a>首席运营官Lisa Drake表示，福特预计将在两年内成为全球第二大电动汽车销售商，年产量接近60万辆，仅次于<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>。据分析师预估，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>有望在2021年销售89万辆汽车。</p>\n<p><b>传<a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>考虑将新疫苗部门上市</b></p>\n<p>据媒体援引消息人士称，<a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>可能将其新成立的疫苗部门上市，以提高投资者的回报。知情人士透露，关于新疫苗部门上市的设想，阿斯利康仍处在早期阶段，公司高层已与顾问讨论了一系列可能性。</p>\n<p><b>推特调整高管团队</b></p>\n<p>据媒体周五报道，推特公司在一份监管文件中表示，负责推特设计和研究的Dantley Davis和工程主管Michael Montano将离开公司。推特表示，这些举措旨在提高问责、速度和运营效率。本周早些时候，推特联合创始人Jack Dorsey宣布辞去CEO一职。</p>\n<p><a href=\"https://laohu8.com/NW/2188200520\" target=\"_blank\"><b>加拿大鹅遭炮轰 股价创2020年3月以来最大周跌幅</b></a></p>\n<p><a href=\"https://laohu8.com/S/GOOS\">加拿大鹅</a>股价本周一度下跌21%，创下2020年3月以来的最差单周表现。近日，加拿大鹅品牌“不得退换”的“霸王条款”引发舆论热议。数据显示，该公司财年第二季度约25%的收入来自亚洲。</p>\n<p><a href=\"https://laohu8.com/NW/2188224515\" target=\"_blank\"><b>BioNTech首席执行官：公司有能力迅速推出针对Omicron的疫苗</b></a></p>\n<p>BioNTech首席执行官Ugur Sahin接受采访时表示，在奥密克戎变异病毒出现后，公司有能力迅速调整其新冠病毒疫苗以针对新变异体。Sahin表示：“我原则上相信，在某个特定的时间点，我们将需要一种专门针对这类变异病毒的新疫苗，但问题是需求是否像去年那样非常迫切。”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/b23574aac95526c9e5c62ebc8dd25130","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数",".DJI":"道琼斯","TTTN":"老虎中美互联网巨头ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177965649","content_text":"摘要：非农数据引发市场巨震，纳指大跌近2%；热门中概股集体大跌，滴滴跌逾22%；美国总统拜登正式签署短期支出法案，政府运营将持续到明年2月；IMF总裁预期全球经济增速将被下调>>>\n\n收盘：非农数据远逊预期 美股周五收跌\n美东时间周五，对奥密克戎变异毒株的担忧情绪仍然主导市场，加上11月非农数据远逊预期，三大指数集体收跌，科技股遭到普遍抛售，纳指盘中一度跌超2.5%。截至收盘，道琼斯指数跌0.17%，报34,580.08点；标普500指数跌0.84%，报4,538.43点；纳斯达克指数跌1.92%，报15,085.50点。\n热门中概股普遍下挫，滴滴跌逾22%\n热门中概股集体大跌，阿里巴巴跌8.23%，京东跌7.71%，微博跌6.34%，拼多多跌8.16%，哔哩哔哩跌7.15%，百度跌7.77%，新东方跌9.22%，网易跌6.90%，腾讯音乐跌11.94%，爱奇艺跌15.74%，滴滴跌22.18%。\n本周美国WTI原油下跌2.8% 连续第六周录得跌幅\n美国原油期货价格丧失了周五早盘的涨幅，最终逆转收跌。该期货连续第六周录得跌幅。纽约商品交易所1月交割的西德克萨斯中质原油（WTI）期货价格下跌24美分，跌幅0.4%，收于每桶66.26美元，盘中最高曾达到69.22美元。根据FactSet的数据，按照最活跃合约计算，本周WTI原油期货价格下跌2.8%，为连续第六周录得跌幅。\n黄金期货价格周五收高1.2% 本周下跌0.1%\n黄金期货价格周五收高，保住了美国11月非农就业数据公布后所获大部分涨幅。但本周金价录得跌幅。纽约商品交易所交投最活跃的2月黄金期货价格上涨21.20美元，涨幅1.2%，收于每盎司1783.90美元。本周黄金期货价格下跌近0.1%。\n欧股主要指数下跌，德国DAX30指数收跌0.7%\n德国DAX30指数周五收跌0.71%，英国富时100指数跌0.14%，法国CAC40指数跌0.44%，欧洲斯托克50指数跌0.70%，西班牙IBEX35指数跌0.76%，意大利富时MIB指数跌0.27%。\n国际宏观\n美国11月非农报告耐人寻味 新增就业年内最低但失业率下降\n美国11月非农就业人数录得今年最小增幅，失业率超预期降至4.2%，虽然这些数据看起来喜忧参半，但仍可能推动美联储加快撤出疫情期间的货币刺激措施。美国劳工部周五公布的数据显示，11月非农就人数增长21万，此前两个月的数据都被向上调整。劳动力参与率微升至61.8%。\nIMF总裁预期全球经济增速将被下调 受omicron变种影响\n国际货币基金组织（IMF）总裁格奥尔基耶娃预计，随着omicron变异毒株的病例数量增加，该组织将削减对全球经济反弹的预期。“我们可能会下调10月份时对全球经济增长的一些预测，”格奥尔基耶娃周五在路透主办的会议上表示。她说，新的变异毒株“可能很快就会削弱信心”。\n美国总统拜登正式签署短期支出法案 政府运营将持续到明年2月\n美国总统拜登当地时间12月3日正式签署了短期支出法案，避免了政府的停摆危机。然而，短期支出法案只能维持政府运营持续到2月18日，国会议员们依然需要在明年年初制定另一项拨款法案。\nIMF喊话美联储：重视通胀风险 尽快加速taper\n国际货币基金组织（IMF）警告称，鉴于美国通胀风险上升，并且奥密克戎变异毒株造成了新的不确定性，美联储官员应加快收紧货币政策的步伐。IMF首席经济学家Gita Gopinath和货币与资本市场部门主管Tobias Adrian撰文称，新冠疫情的复苏以及奥密克戎变异毒株的蔓延大大增加了全球经济的不确定性。\n公司新闻\n默沙东将向加拿大提供至多100万疗程新冠药物\n默沙东周五表示，将向加拿大提供至多100万疗程的新冠口服药物molnupiravir。据悉，加拿大政府已确保将在2022年采购50万疗程的molnupiravir，剩下50万疗程正等待加拿大卫生部的批准。\n谷歌和梅塔公司将再度面临被俄罗斯一法院罚款\n据媒体报道，俄罗斯首都莫斯科塔甘斯基第422号地方法院将于12月24日举行听证会，审理由俄联邦电信、信息技术和大众传媒监督局提交的谷歌和梅塔公司（原脸书公司）行政犯罪的记录。上述公司没有按照规定删除被俄罗斯官方禁止传播的信息和内容，或将面临最高达其年收入总额十分之一的罚款。\n福特目标在两年内成为全球第二大电动车销售商\n当地时间周五，福特汽车首席运营官Lisa Drake表示，福特预计将在两年内成为全球第二大电动汽车销售商，年产量接近60万辆，仅次于特斯拉。据分析师预估，特斯拉有望在2021年销售89万辆汽车。\n传阿斯利康考虑将新疫苗部门上市\n据媒体援引消息人士称，阿斯利康可能将其新成立的疫苗部门上市，以提高投资者的回报。知情人士透露，关于新疫苗部门上市的设想，阿斯利康仍处在早期阶段，公司高层已与顾问讨论了一系列可能性。\n推特调整高管团队\n据媒体周五报道，推特公司在一份监管文件中表示，负责推特设计和研究的Dantley Davis和工程主管Michael Montano将离开公司。推特表示，这些举措旨在提高问责、速度和运营效率。本周早些时候，推特联合创始人Jack Dorsey宣布辞去CEO一职。\n加拿大鹅遭炮轰 股价创2020年3月以来最大周跌幅\n加拿大鹅股价本周一度下跌21%，创下2020年3月以来的最差单周表现。近日，加拿大鹅品牌“不得退换”的“霸王条款”引发舆论热议。数据显示，该公司财年第二季度约25%的收入来自亚洲。\nBioNTech首席执行官：公司有能力迅速推出针对Omicron的疫苗\nBioNTech首席执行官Ugur Sahin接受采访时表示，在奥密克戎变异病毒出现后，公司有能力迅速调整其新冠病毒疫苗以针对新变异体。Sahin表示：“我原则上相信，在某个特定的时间点，我们将需要一种专门针对这类变异病毒的新疫苗，但问题是需求是否像去年那样非常迫切。”","news_type":1},"isVote":1,"tweetType":1,"viewCount":512,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875628055,"gmtCreate":1637646197373,"gmtModify":1637646200152,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098678914535810","idStr":"4098678914535810"},"themes":[],"htmlText":"Hmmm… both","listText":"Hmmm… both","text":"Hmmm… both","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875628055","repostId":"1107351089","repostType":4,"repost":{"id":"1107351089","kind":"news","pubTimestamp":1637623277,"share":"https://www.laohu8.com/m/news/1107351089?lang=&edition=full","pubTime":"2021-11-23 07:21","market":"us","language":"en","title":"Nvidia or AMD: Which Stock Is the Better Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=1107351089","media":"TheStreet","summary":"Semiconductor stocks have been on fire this year. NVDA and AMD are among the most popular stocks on ","content":"<p>Semiconductor stocks have been on fire this year. NVDA and AMD are among the most popular stocks on the main Reddit forums – but which is a better pick?</p>\n<p>The semiconductor industry has been under “bullish attack” in 2021. The iShares Semiconductor ETF(<b>SOXX</b>)&nbsp;is up more than 50% in the past year, with two of the most relevant players in the sector competing for the spotlight: NVIDIA&nbsp;and Advanced Micro Devices(<b>AMD</b>).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3401b1f213322e232b5914c45385c546\" tg-width=\"687\" tg-height=\"625\" width=\"100%\" height=\"auto\"><span>Figure 1: NVDA, AMD and SOXX price chart over 1-year period.</span></p>\n<p>The rally has been fueled by several catalysts: sustainable revenue growth with long-term opportunities in areas like games, EV and the metaverse; rich gross margins; and strong balance sheets. Today, we look at NVIDIA and AMD stocks and ask the question: which of these two is a better buy at current levels?</p>\n<p><b>NVDA stock according to Wall Street</b></p>\n<p>NVDA has a consensus strong buy rating by Wall Street experts, based on 24 reports released in the past 3 months. The average price target on the stock is $356, which represents very modest 8% upside potential from current levels.</p>\n<p>The chip company announced Q3 results on November 17. Since then, analysts have reinforced their bullishness as the stock surged another 12% after earnings.</p>\n<ul>\n <li>Bank of America analyst Vivek Arya&nbsp;raised&nbsp;the company’s price target to $375.00 from $340.00 after earnings, pointing at 14% upside potential. The analyst sees NVDA’s having a unique combination of “highly leverageable silicon, software, scale and systems expertise” that will continue to position it at the forefront of some of the largest and fastest growth markets in tech.</li>\n</ul>\n<ul>\n <li>Craig-Hallum analyst Richard Shannon also&nbsp;raised&nbsp;NVDA’s price target after earnings to $350 from $220, suggesting modest gain opportunity of 6%. While he keeps a buy rating on the shares, he also suspects that the gaming cycle has hit its peak. Still, the analyst is raising estimates as nothing seems to be slowing NVIDIA in the data center.</li>\n</ul>\n<ul>\n <li>Susquehanna analyst Christopher Rolland&nbsp;reiterated&nbsp;his buy recommendation on NVDA after earnings, forecasting a 9% upside potential. The analyst sees data center as the star of the show, and he expects to see even more growth in 4Q.</li>\n</ul>\n<p><b>AMD stock according to Wall Street</b></p>\n<p>Analysts are also bullish on AMD stock, based on 22 recent reports. But the recommendation, in this case, is only a “moderate buy” and the $142 average price target counterintuitively represents 9% downside potential. AMD share price has probably run to fast for Wall Street to catch up.</p>\n<ul>\n <li>Wedbush analyst Matt Bryson&nbsp;maintained&nbsp;a buy recommendation a few days ago and raised AMD’s price target to $165 for mid-single digit upside potential. According to the analyst, \"so as long as AMD executes,\" the company should be able to gain share over the mid-term to fuel growth over the next few years. Mr. Bryson also mentioned AMD's data center, which makes him more confident in the thesis.</li>\n</ul>\n<ul>\n <li>Goldman Sachs’ Toshiya Hari, also an AMD bull,raised&nbsp;the share price target to $170. The analyst seemed surprised by the Meta/Facebook design win since the company has historically been a loyal user of Intel processors. The expert is also encouraged by the company's updated server CPU product pipeline. In the end, AMD should grow market share, margins, EPS, and FCF beyond what Wall Street has been modeling, according to Goldman.</li>\n</ul>\n<ul>\n <li>Jefferies analyst Mark Lipacis is another one with a buy&nbsp;recommendation&nbsp;on AMD, but his $145 price target on the stock represents downside risk of 7%. The analyst’s bull case relies on Meta Platforms being a huge deal win for AMD to accelerate market share gains.</li>\n</ul>\n<p><b>Wall Street Memes’ take</b></p>\n<p>The fundamentals of both NVDA and AMD appear to be as strong as ever. Accelerated growth in the core business segments and upbeat outlook should appeal to growth investors. However, such expectations for future financial results could be valuing NVDA and AMD at too rich a multiple.</p>\n<p>NVDA, for instance, trades at a current P/E ratio of 74 times – the second highest multiple among the 20 largest companies by market cap, only trailing Tesla TSLA). AMD, valued at a slightly lower P/E ratio of 64 times, cannot be considered a bargain either.</p>\n<p>More easily than finding many fundamental differences between NVDA and AMD, we see more similarities between the stocks. Both companies should attract growth investors who think that the long-term opportunities in tech might be underappreciated today. The more value-conscious investor, however, will probably be discouraged by the valuation multiples in both cases.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia or AMD: Which Stock Is the Better Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia or AMD: Which Stock Is the Better Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-23 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/memestocks/reddit-trends/nvidia-or-amd-stock-which-is-a-better-buy-now><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Semiconductor stocks have been on fire this year. NVDA and AMD are among the most popular stocks on the main Reddit forums – but which is a better pick?\nThe semiconductor industry has been under “...</p>\n\n<a href=\"https://www.thestreet.com/memestocks/reddit-trends/nvidia-or-amd-stock-which-is-a-better-buy-now\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司","NVDA":"英伟达"},"source_url":"https://www.thestreet.com/memestocks/reddit-trends/nvidia-or-amd-stock-which-is-a-better-buy-now","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107351089","content_text":"Semiconductor stocks have been on fire this year. NVDA and AMD are among the most popular stocks on the main Reddit forums – but which is a better pick?\nThe semiconductor industry has been under “bullish attack” in 2021. The iShares Semiconductor ETF(SOXX) is up more than 50% in the past year, with two of the most relevant players in the sector competing for the spotlight: NVIDIA and Advanced Micro Devices(AMD).\nFigure 1: NVDA, AMD and SOXX price chart over 1-year period.\nThe rally has been fueled by several catalysts: sustainable revenue growth with long-term opportunities in areas like games, EV and the metaverse; rich gross margins; and strong balance sheets. Today, we look at NVIDIA and AMD stocks and ask the question: which of these two is a better buy at current levels?\nNVDA stock according to Wall Street\nNVDA has a consensus strong buy rating by Wall Street experts, based on 24 reports released in the past 3 months. The average price target on the stock is $356, which represents very modest 8% upside potential from current levels.\nThe chip company announced Q3 results on November 17. Since then, analysts have reinforced their bullishness as the stock surged another 12% after earnings.\n\nBank of America analyst Vivek Arya raised the company’s price target to $375.00 from $340.00 after earnings, pointing at 14% upside potential. The analyst sees NVDA’s having a unique combination of “highly leverageable silicon, software, scale and systems expertise” that will continue to position it at the forefront of some of the largest and fastest growth markets in tech.\n\n\nCraig-Hallum analyst Richard Shannon also raised NVDA’s price target after earnings to $350 from $220, suggesting modest gain opportunity of 6%. While he keeps a buy rating on the shares, he also suspects that the gaming cycle has hit its peak. Still, the analyst is raising estimates as nothing seems to be slowing NVIDIA in the data center.\n\n\nSusquehanna analyst Christopher Rolland reiterated his buy recommendation on NVDA after earnings, forecasting a 9% upside potential. The analyst sees data center as the star of the show, and he expects to see even more growth in 4Q.\n\nAMD stock according to Wall Street\nAnalysts are also bullish on AMD stock, based on 22 recent reports. But the recommendation, in this case, is only a “moderate buy” and the $142 average price target counterintuitively represents 9% downside potential. AMD share price has probably run to fast for Wall Street to catch up.\n\nWedbush analyst Matt Bryson maintained a buy recommendation a few days ago and raised AMD’s price target to $165 for mid-single digit upside potential. According to the analyst, \"so as long as AMD executes,\" the company should be able to gain share over the mid-term to fuel growth over the next few years. Mr. Bryson also mentioned AMD's data center, which makes him more confident in the thesis.\n\n\nGoldman Sachs’ Toshiya Hari, also an AMD bull,raised the share price target to $170. The analyst seemed surprised by the Meta/Facebook design win since the company has historically been a loyal user of Intel processors. The expert is also encouraged by the company's updated server CPU product pipeline. In the end, AMD should grow market share, margins, EPS, and FCF beyond what Wall Street has been modeling, according to Goldman.\n\n\nJefferies analyst Mark Lipacis is another one with a buy recommendation on AMD, but his $145 price target on the stock represents downside risk of 7%. The analyst’s bull case relies on Meta Platforms being a huge deal win for AMD to accelerate market share gains.\n\nWall Street Memes’ take\nThe fundamentals of both NVDA and AMD appear to be as strong as ever. Accelerated growth in the core business segments and upbeat outlook should appeal to growth investors. However, such expectations for future financial results could be valuing NVDA and AMD at too rich a multiple.\nNVDA, for instance, trades at a current P/E ratio of 74 times – the second highest multiple among the 20 largest companies by market cap, only trailing Tesla TSLA). AMD, valued at a slightly lower P/E ratio of 64 times, cannot be considered a bargain either.\nMore easily than finding many fundamental differences between NVDA and AMD, we see more similarities between the stocks. Both companies should attract growth investors who think that the long-term opportunities in tech might be underappreciated today. The more value-conscious investor, however, will probably be discouraged by the valuation multiples in both cases.","news_type":1},"isVote":1,"tweetType":1,"viewCount":669,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602030171,"gmtCreate":1638937159242,"gmtModify":1638937159242,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098678914535810","idStr":"4098678914535810"},"themes":[],"htmlText":"Thanks for the advice. Will seriously consider if selling is imminent… or later?","listText":"Thanks for the advice. Will seriously consider if selling is imminent… or later?","text":"Thanks for the advice. Will seriously consider if selling is imminent… or later?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602030171","repostId":"1105817084","repostType":4,"repost":{"id":"1105817084","kind":"news","pubTimestamp":1638933976,"share":"https://www.laohu8.com/m/news/1105817084?lang=&edition=full","pubTime":"2021-12-08 11:26","market":"us","language":"en","title":"Apple Stock: What Happens When The Cash Runs Out?","url":"https://stock-news.laohu8.com/highlight/detail?id=1105817084","media":"TheStreet","summary":"Apple is about to run out of cash. This statement may sound lucrac is to most Apple stock  investors, since the Cupertino company has been a cash-generating machine in the past many years. But even the management team knows this to be true.Today, the Apple Maven talks about what has been happening to the iPhone maker’s once giant pile of cash, and what the declining balances may mean for shareholders.To be fair, “running out of cash” in this context does not mean that Apple’s checking accounts a","content":"<p>Apple is about to run out of cash. This statement may sound lucrac&nbsp;is to most Apple stock&nbsp;(<b>AAPL</b>)&nbsp;investors, since the Cupertino company has been a cash-generating machine in the past many years. But even the management team&nbsp;knows&nbsp;this to be true.</p>\n<p>Today, the Apple Maven talks about what has been happening to the iPhone maker’s once giant pile of cash, and what the declining balances may mean for shareholders.</p>\n<p><b>Apple heading to net cash neutral</b></p>\n<p>To be fair, “running out of cash” in this context does not mean that Apple’s checking accounts at the bank will dry out. It simply means that the company’s debt balances will roughly offset its cash position — i.e. Apple will become net cash neutral.</p>\n<p>The chart below shows the evolution of Apple’s gross cash (blue bars) and net cash (orange bars) balances since 2011. Ten years ago was when then-CEO Steve Jobs stepped down and turned the control of the company over to then-COO Tim Cook.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/435c5199979bc64d49899feed29d15fb\" tg-width=\"1200\" tg-height=\"723\" width=\"100%\" height=\"auto\"><span>Figure 2:Apple's cash position, fiscal 2012-2021.data from Seeking Alpha</span></p>\n<p>Starting in 2012, Apple began issuing debt for the first time in its history. By 2017, the company boasted the largest gross and net-of-debt cash balances that it had ever seen in its books. But since then, both numbers have been dwindling. This year’s $72 billion in net cash is less than half the amount of about four years ago.</p>\n<p><b>What happens when cash runs out?</b></p>\n<p>The chart below shows that, prior to Tim Cook as CEO, Apple was very timid at deploying its cash reserves. While capex and dividend payments increased quickly (large M&amp;A has never been a thing for Apple), buybacks skyrocketed. Apple has spent more than three times as much in share repurchases since 2018 than it did in capex and dividends combined.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e0ecee1dedf8551b616732dc7180c574\" tg-width=\"1200\" tg-height=\"694\" width=\"100%\" height=\"auto\"><span>Figure 3:Apple's cash deployment by major category.data from Seeking Alpha</span></p>\n<p>As Apple’s cash balance continues to dip, it is reasonable to expect the pace of share retirement to decline as well. This is true not only because of a leaner balance sheet, but because AAPL stock trades at a much richer price today — thus, it costs Apple more to buy back each share of its own equity.</p>\n<p>Why is this relevant for investors? Over the past decade, Apple’s shares outstanding have declined by 10 billion units to 16.7 billion. Share count is the denominator in EPS (earnings per share) and EPS is the denominator in price-to-earnings. Therefore, buybacks alone have probably been responsible for a good chunk of Apple stock’s climb in the past several years.</p>\n<p>At the current stock price of $165 apiece, Apple can afford to retire around 435 million more shares with its current net cash balance, or barely 3% of the float. After that point, the Cupertino company might need to scale back on repurchases or borrow in order to keep buying its stock.</p>\n<p><b>Should investors worry?</b></p>\n<p>I think that Apple stock could suffer, at least from deteriorated investor sentiment, if or once it begins to slow down the pace of its share buyback efforts. However, I also believe that this is only one aspect of the investment thesis that people should consider.</p>\n<p>I remain optimistic about Apple stock from a business fundamentals perspective. The Cupertino company seems to have found the sweet spot in demand for its products and services, which I believe bodes very well for AAPL in the foreseeable future.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: What Happens When The Cash Runs Out?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: What Happens When The Cash Runs Out?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-08 11:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/apple-stock-what-happens-when-the-cash-runs-out><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple is about to run out of cash. This statement may sound lucrac is to most Apple stock (AAPL) investors, since the Cupertino company has been a cash-generating machine in the past many years. But ...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/apple-stock-what-happens-when-the-cash-runs-out\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/apple-stock-what-happens-when-the-cash-runs-out","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105817084","content_text":"Apple is about to run out of cash. This statement may sound lucrac is to most Apple stock (AAPL) investors, since the Cupertino company has been a cash-generating machine in the past many years. But even the management team knows this to be true.\nToday, the Apple Maven talks about what has been happening to the iPhone maker’s once giant pile of cash, and what the declining balances may mean for shareholders.\nApple heading to net cash neutral\nTo be fair, “running out of cash” in this context does not mean that Apple’s checking accounts at the bank will dry out. It simply means that the company’s debt balances will roughly offset its cash position — i.e. Apple will become net cash neutral.\nThe chart below shows the evolution of Apple’s gross cash (blue bars) and net cash (orange bars) balances since 2011. Ten years ago was when then-CEO Steve Jobs stepped down and turned the control of the company over to then-COO Tim Cook.\nFigure 2:Apple's cash position, fiscal 2012-2021.data from Seeking Alpha\nStarting in 2012, Apple began issuing debt for the first time in its history. By 2017, the company boasted the largest gross and net-of-debt cash balances that it had ever seen in its books. But since then, both numbers have been dwindling. This year’s $72 billion in net cash is less than half the amount of about four years ago.\nWhat happens when cash runs out?\nThe chart below shows that, prior to Tim Cook as CEO, Apple was very timid at deploying its cash reserves. While capex and dividend payments increased quickly (large M&A has never been a thing for Apple), buybacks skyrocketed. Apple has spent more than three times as much in share repurchases since 2018 than it did in capex and dividends combined.\nFigure 3:Apple's cash deployment by major category.data from Seeking Alpha\nAs Apple’s cash balance continues to dip, it is reasonable to expect the pace of share retirement to decline as well. This is true not only because of a leaner balance sheet, but because AAPL stock trades at a much richer price today — thus, it costs Apple more to buy back each share of its own equity.\nWhy is this relevant for investors? Over the past decade, Apple’s shares outstanding have declined by 10 billion units to 16.7 billion. Share count is the denominator in EPS (earnings per share) and EPS is the denominator in price-to-earnings. Therefore, buybacks alone have probably been responsible for a good chunk of Apple stock’s climb in the past several years.\nAt the current stock price of $165 apiece, Apple can afford to retire around 435 million more shares with its current net cash balance, or barely 3% of the float. After that point, the Cupertino company might need to scale back on repurchases or borrow in order to keep buying its stock.\nShould investors worry?\nI think that Apple stock could suffer, at least from deteriorated investor sentiment, if or once it begins to slow down the pace of its share buyback efforts. However, I also believe that this is only one aspect of the investment thesis that people should consider.\nI remain optimistic about Apple stock from a business fundamentals perspective. The Cupertino company seems to have found the sweet spot in demand for its products and services, which I believe bodes very well for AAPL in the foreseeable future.","news_type":1},"isVote":1,"tweetType":1,"viewCount":613,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609779087,"gmtCreate":1638332392917,"gmtModify":1638332392917,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098678914535810","idStr":"4098678914535810"},"themes":[],"htmlText":"Let’s pray that vaccines available still continue to work on all variants…","listText":"Let’s pray that vaccines available still continue to work on all variants…","text":"Let’s pray that vaccines available still continue to work on all variants…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609779087","repostId":"1134775339","repostType":2,"repost":{"id":"1134775339","kind":"news","pubTimestamp":1638325598,"share":"https://www.laohu8.com/m/news/1134775339?lang=&edition=full","pubTime":"2021-12-01 10:26","market":"us","language":"en","title":"Is a Stock Market Correction Coming? Here’s a Big Red Flag","url":"https://stock-news.laohu8.com/highlight/detail?id=1134775339","media":"Barrons","summary":"To say that the Omicron variant is shaking the market would be an understatement. But add that stock","content":"<p>To say that the Omicron variant is shaking the market would be an understatement. But add that stocks are more expensive than they’ve ever been—and a true correction now wouldn’t surprise anybody.</p>\n<p>The S&amp;P 500 has fallen almost 3% from its all-time high hit in late November, just before scientists in South Africa reported the new Covid-19 strain. On Friday, the market had its worst day of the year. Tuesday was more ugliness—producers of vaccines and treatments predicted their remedies probably wouldn’t be as effective against Omicron as other variants.</p>\n<p>But that true correction—a 10% drop—has been elusive, even during all these months of the pandemic. And that itself is a bit astonishing, since corrections are often a normal part of a larger bull market.</p>\n<p>One indicator, though, forecasts a correction—like a dark cloud usually brings rain. The total U.S. equity market capitalization is about 215% of U.S. gross domestic product—the highest level ever, according to Global Financial Data.</p>\n<p>Such a high number isn’t good. It’s bad, often a sign that a correction is just around the corner</p>\n<p>In 1929, market cap to GDP hit an all-time high of about 100%, just before the famous stock market crash late that year. In 2000, another high at about 150%, just before a bear market—a drop of at least 20%—began. In 2008, a multiyear high, just ahead of the financial crisis.</p>\n<p>The upshot: Maybe a correction; then again, maybe not. It’s all in the hands of investors.</p>\n<p>To be sure, stock valuations aren’t known to be the best timing tool for investors deciding if they should do more buying or selling. Valuations can stay high for a long time.</p>\n<p>For most of the pandemic era, in fact, the market has been valued at its highest level relative to GDP ever. But high valuations do indicate that when—and if—the economic outlook really does deteriorate, stocks can fall really hard.</p>\n<p>“There is certainly the potential for additional market drops and heightened volatility in coming weeks as a result of this variant, especially given all the uncertainty surrounding it,” wrote Kristina Hooper, chief global market strategist at Invesco. “There is room for a decent correction.”</p>\n<p>What the market needs now is a little hope—that vaccines will be effective against the new variant. Otherwise, get ready for a correction.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is a Stock Market Correction Coming? Here’s a Big Red Flag</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs a Stock Market Correction Coming? Here’s a Big Red Flag\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/stock-market-correction-51638305804?mod=newsviewer_click_seemore><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>To say that the Omicron variant is shaking the market would be an understatement. But add that stocks are more expensive than they’ve ever been—and a true correction now wouldn’t surprise anybody.\nThe...</p>\n\n<a href=\"https://www.marketwatch.com/articles/stock-market-correction-51638305804?mod=newsviewer_click_seemore\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/articles/stock-market-correction-51638305804?mod=newsviewer_click_seemore","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1134775339","content_text":"To say that the Omicron variant is shaking the market would be an understatement. But add that stocks are more expensive than they’ve ever been—and a true correction now wouldn’t surprise anybody.\nThe S&P 500 has fallen almost 3% from its all-time high hit in late November, just before scientists in South Africa reported the new Covid-19 strain. On Friday, the market had its worst day of the year. Tuesday was more ugliness—producers of vaccines and treatments predicted their remedies probably wouldn’t be as effective against Omicron as other variants.\nBut that true correction—a 10% drop—has been elusive, even during all these months of the pandemic. And that itself is a bit astonishing, since corrections are often a normal part of a larger bull market.\nOne indicator, though, forecasts a correction—like a dark cloud usually brings rain. The total U.S. equity market capitalization is about 215% of U.S. gross domestic product—the highest level ever, according to Global Financial Data.\nSuch a high number isn’t good. It’s bad, often a sign that a correction is just around the corner\nIn 1929, market cap to GDP hit an all-time high of about 100%, just before the famous stock market crash late that year. In 2000, another high at about 150%, just before a bear market—a drop of at least 20%—began. In 2008, a multiyear high, just ahead of the financial crisis.\nThe upshot: Maybe a correction; then again, maybe not. It’s all in the hands of investors.\nTo be sure, stock valuations aren’t known to be the best timing tool for investors deciding if they should do more buying or selling. Valuations can stay high for a long time.\nFor most of the pandemic era, in fact, the market has been valued at its highest level relative to GDP ever. But high valuations do indicate that when—and if—the economic outlook really does deteriorate, stocks can fall really hard.\n“There is certainly the potential for additional market drops and heightened volatility in coming weeks as a result of this variant, especially given all the uncertainty surrounding it,” wrote Kristina Hooper, chief global market strategist at Invesco. “There is room for a decent correction.”\nWhat the market needs now is a little hope—that vaccines will be effective against the new variant. Otherwise, get ready for a correction.","news_type":1},"isVote":1,"tweetType":1,"viewCount":906,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874183713,"gmtCreate":1637743910331,"gmtModify":1637743910331,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098678914535810","idStr":"4098678914535810"},"themes":[],"htmlText":"Bought some for long terms gain… 😄","listText":"Bought some for long terms gain… 😄","text":"Bought some for long terms gain… 😄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874183713","repostId":"2185804343","repostType":2,"isVote":1,"tweetType":1,"viewCount":865,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844218737,"gmtCreate":1636429829281,"gmtModify":1636430056505,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4098678914535810","idStr":"4098678914535810"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>Up up all the way 😄","listText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>Up up all the way 😄","text":"$Lucid Group Inc(LCID)$Up up all the way 😄","images":[{"img":"https://static.tigerbbs.com/6d051f1bdcdd23ae132420f6f7bf3c8d","width":"1125","height":"2710"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844218737","isVote":1,"tweetType":1,"viewCount":714,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"lives":[]}